Selection from HEOR Bibliography
| Search criteria | ||||
| Cardiovascular disease |
||||
| Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment | ||||
| Rockberg J1, Jørgensen L1, Taylor B2, Sobocki P1, Johansson G3. | ||||
| 1 QuintilesIMS, Solna, Sweden. 2 Amgen Inc, Thousand Oaks, CA, USA. 3 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. | ||||
| Prev Med Rep | ||||
| Article | ||||
| Sweden | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374870/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2017 | English | Real World Evidence | |
| The treatment of paroxysmal atrial fibrillation in UK primary care | ||||
| Andrea Isaew, Nicola Jaime Adderley, Ronan Ryan, David Fitzmaurice, Tom Marshall | ||||
| University of Birmingham | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2017 | English | Retrospective database analysis | |
| CHARACTERIZATION OF STATIN EFFECTIVENESS USING REAL-WORLD DATA IN A CANADIAN POPULATION | ||||
| Shojaie S, McCurdy S, Thiele S, Ching Chau L, Martin L, Charland K, Dobson-Belaire W, Duclos M, Borrelli R | ||||
| IMS Health Brogan., Mississauga, ON, Canada, IMS health Brogan, Kirkland, QC, Canada, IMS Health Brogan, Mississauga, ON, Canada | ||||
| ISPOR 21st, May 2016, Washington, DC USA | ||||
| Poster | ||||
| Canada | ||||
| Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/statin-ispor-poster-2016.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Retrospective database analysis | |
| TREATMENT PATTERNS AMONG PATIENTS PRESCRIBED PDE-5 INHIBITOR MONOTHERAPY FOR PULMONARY HYPERTENSION | ||||
| Yeaw J, Lickert C, Drake W, De AP, Wade RL | ||||
| 1IMS Health, San Francisco, CA, USA, 2Actelion Pharmaceuticals, Inc., South San Francisco, CA, USA, 3IMS Health, Plymouth Meeting, PA, USA | ||||
| ISPOR 21th, May 2016, Washington DC USA | ||||
| Poster | ||||
| USA | ||||
| Abstract: www.ispor.org | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | ||
| Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden. | ||||
| Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1,3, Johansson G4, Levin LÅ5, Sobocki P3,6, Gandra SR7. | ||||
| 1Quantify Research, Stockholm, Sweden. 2Strategic Healthcare Solutions, LLC, Baltimore, MD, USA. 3LIME/Medical Management Centre, Karolinska Institute, Stockholm, Sweden. 4Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. 5Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 6IMS Health, Stockholm, Sweden. 7Amgen Inc., Thousand Oaks, CA, United States. | ||||
| Int J Clin Pract | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819716/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Epidemiological study | |
| Exposure to heart failure treatments in newly diagnosed patients in Sweden | ||||
| G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7, | ||||
| 1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Department of Public Health and Clinical Medicine - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden | ||||
| European Journal of Heart Failure, 2016, Vol. 18, 48-48 p. | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.539/epdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Real World Evidence | |
| Dosing of heart failure treatments in newly diagnosed unselected patients in Sweden: compliance with European society of cardiology guidelines | ||||
| G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7 | ||||
| 1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden | ||||
| European Journal of Heart Failure | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.539/epdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Real World Evidence | |
| Recent trends in diagnostic work-up among unselected patients newly diagnosed with heart failure: a Swedish population-based study | ||||
| J Stalhammar1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, G Wikstrom7 | ||||
| 1Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Institute for Medical Sciences - Uppsala - Sweden | ||||
| European Journal of Heart Failure | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.539/epdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Real World Evidence | |
| A description of unselected patients with heart failure: a swedish population-based study | ||||
| J Stalhammar1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, G Wikstrom7 | ||||
| 1Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Institute for Medical Sciences - Uppsala - Sweden | ||||
| European Journal of Heart Hailure | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.539/epdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Real World Evidence | |
| Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care. | ||||
| Colivicchi F1, Gulizia MM2, Franzini L3, Imperoli G4, Castello L1, Aiello A1, Ripellino C5, Cataldo N5. | ||||
| 1 Cardiology Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy 2 Cardiology Division, Garibaldi Nesima Hospital,Catania, Italy 3 AstraZeneca S.p.A., Milan, Italy 4 Internal Medicine Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy 5 IMS Health Information Solutions Italy S.r.l., Milan, Italy | ||||
| Advances in Therapy, 2016, [Epub ahead of print]. | ||||
| Manuscript in preparation | ||||
| Italy | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Clinical+Implications+of+Switching+Lipid+Lowering+Treatment+from+Rosuvastatin+to+Other+Agents+in+Primary+Care | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Metabolic Disorders | 2016 | English | Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis | |
| Rosuvastatin: switching treatment and clinical implications in primary care. | ||||
| Heiman F1, Ripellino C1, Colivicchi F2. | ||||
| 1 IMS Health Information Solutions Italy Srl 2 Cardiology Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy. | ||||
| Poster | ||||
| Italy | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Metabolic Disorders | 2016 | English | Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis | |
| Pharmacoutilization in patients suffering from non-valvular atrial fibrillation. | ||||
| Cataldo N1, Ripellino C1, Di Virgilio R, De Solda S. | ||||
| 1 IMS Health Information Solutions Italy, Srl, Milan, Italy. | ||||
| ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. | ||||
| Poster | ||||
| Italy | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Database Study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis | |
| Assessing the cost-effectiveness of transcatheter aortic valve implantation in operable patients with severe aortic stenosis in UK. | ||||
| Ramos M1, Lamotte M1, Chevalier P1, Goodall G2 | ||||
| 1 QuintilesIMS, Zaventem, Belgium 2 Edwards Lifesciences, Nyon, Switzerland | ||||
| 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria | ||||
| Abstract | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Cost effectiveness, Cost utility | |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. | ||||
| Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 | ||||
| 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium | ||||
| 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria | ||||
| Abstract | ||||
| Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | ||
| Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting. | ||||
| Hasvold P1,2, Thuresson M3, Sundström J4, Hammar N5,6, Kjeldsen SE7,8, Johansson G9, Holme I10, Bodegård J11. | ||||
| 1AstraZeneca, 151 85, Södertälje, Sweden. paal.hasvold@astrazeneca.com. 2Medical Faculty, University of Oslo, 0424, Oslo, Norway. paal.hasvold@astrazeneca.com. 3Statisticon AB, 753 22, Uppsala, Sweden. 4Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, 751 05, Uppsala, Sweden. 5Institute of Environmental Medicine, Karolinska Institute, 171 77, Stockholm, Sweden. 6Medical Evidence and Observational Research, AZ R&D, Mölndal, Sweden. 7Medical Faculty, University of Oslo, 0424, Oslo, Norway. 8Department of Cardiology, Oslo University Hospital, Oslo, Norway. 9Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, 751 05, Uppsala, Sweden. 10Department of Sports Medicine, Norwegian School of Sport Sciences, PO Box 4014, Ulleval Stadion, 0806, Oslo, Norway. 11AstraZeneca, 151 85, Södertälje, Sweden. | ||||
| Clin Drug Investig | ||||
| Article | ||||
| Sweden | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761013/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Real World Evidence | |
| Leveraging real-world evidence in disease management decision-making with a total cost of care (TCoC) estimator. American drug and health benefits. | ||||
| Nguyen TN, Trocio J, Kowal S, Ferrufino C; Munakata J,South D | ||||
| American Drug and Health Benefits. 2016 December; 9(9):475-484 | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Abstract: http://www.ahdbonline.com/issues/2016/december-2016-vol-9-no-9/2276-leveraging-real-world-evidence-in-disease-management-decision-making-with-a-total-cost-of-care-estimator | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Cost analysis | |
| Minimizing burden of disease-related hospitalization among pulmonary arterial hypertension patients. | ||||
| Li S, Highland K, Cole M, Bilir P, Tsang Y, Graber-Naidich A, Kowal S, Drake W | ||||
| Academy of Managed Care Pharmacy (AMCP) Nexus 2016 Conference, 2016, October 3-6, National Harbor, Maryland | ||||
| Abstract | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Budget impact, Cost analysis | |
| Market uptake of direct oral anticoagulants (DOACS) in germany | ||||
| Batscheider A1, Greese B1, Dannemann S1, Gaba D2, Paulus G1, Stöcker P1, Greiner R1 | ||||
| 1 QuintilesIMS, Munich, Germany 2 QuintilesIMS, Gurgaon, India | ||||
| Poster | ||||
| Germany, India | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Market impact | |
| Estimating Canadian Heart Failure Prevalence Using Prescription Treatment Patterns | ||||
| Jobin Gervais K1, Zaour N1, Caron J2, Borrelli R2, Fischer A2 | ||||
| 1 Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada 2 IMS Brogan, Mississauga, ON, Canada | ||||
| Poster | ||||
| Canada | ||||
| Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/novartis-heart-failure-poster-2016.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Retrospective cohort analysis | |
| A Novel Method Using Prescription Treatment Patterns to Estimate Heart Failure Prevalence in Canada | ||||
| Jobin Gervais K1, Zaour N1, Caron J2, Borrelli R2, Fischer A2 | ||||
| 1 Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada 2 IMS Brogan, Mississauga, ON, Canada | ||||
| Poster | ||||
| Canada | ||||
| Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/novartis-ispor-poster-2016.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Retrospective cohort analysis | |
| Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes | ||||
| Anyanwagu U, Mamza J, Mehta R, Donnelly R, Idris I | ||||
| Division of Medical Sciences & Graduate Entry Medicine, School of Medicine; Research Design Services (East Midlands), School of Medicine | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes, Miscellaneous | 2016 | English | Retrospective database analysis | |
| Type 2 diabetes, high blood pressure and acute pancreatitis | ||||
| Bexelius TS, Ljung R, Garcia Rodriguez LA | ||||
| Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, and Department of Medical Epidemiology and Biostatistics, Karolinska Institute | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes, Miscellaneous | 2016 | English | Retrospective database analysis | |
| Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses | ||||
| González-Pérez A, Sáez ME, Johansson S, Himmelmann A, García Rodríguez LA | ||||
| Spanish Centre for Pharmacoepidemiologic Research (CEIFE) | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Retrospective database analysis | |
| Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care | ||||
| Martín-Pérez M, Ruigómez A, Michel A, García Rodríguez LA | ||||
| Epidemiology, Bayer Pharma AG | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Retrospective database analysis | |
| Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure | ||||
| Martín-Pérez M, Ruigómez A, Michel A, García Rodríguez LA | ||||
| Spanish Centre for Pharmacoepidemiologic Research (CEIFE); Bayer Pharma AG, Epidemiology | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Retrospective database analysis | |
| Incidence and risk factors for severe renal impairment after first diagnosis of heart failure: A cohort and nested case-control study in UK general practice | ||||
| Michel A, Martín-Pérez M, Ruigómez A, García Rodríguez LA | ||||
| Bayer Pharma AG ; Spanish Centre for Pharmacoepidemiologic Research (CEIFE) | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Retrospective database analysis | |
| Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data | ||||
| O'Keeffe AG, Nazareth I, Petersen I | ||||
| Department of Statistical Science, University College London; Department of Primary Care and Population Health, University College London | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Drug Utlization Study | 2016 | English | Retrospective database analysis | |
| Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality | ||||
| Ruigómez A, Michel A, Martín-Pérez M, García Rodríguez LA | ||||
| Spanish Centre for Pharmacoepidemiological Research (CEIFE); Global Epidemiology, Bayer Pharma AG | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Cardiovascular disease | 2016 | English | Retrospective database analysis | |
| Ongoing impairments following transient ischaemic attack: retrospective cohort study | ||||
| Turner GM, Calvert M, Feltham MG, Ryan R, Marshall T | ||||
| Institute of Applied Health Research, University of Birmingham | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2016 | English | Retrospective database analysis | |
| THE ECONOMIC BURDEN OF POOR ADHERENCE TO STATINS IN BELGIUM | ||||
| Ramos M, Caekelbergh K, Lamotte M | ||||
| IMS Health, Vilvoorde, Belgium | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 | ||||
| Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Burden of illness, Cost analysis | |
| AN ASSESMENT OF ENOXAPARINE BENEFIT ON HEALTHCARE BUDGET IN SPAIN | ||||
| Delgado M1, Restovic G2, Planellas L2, Rubio M1, Miñarro C3 | ||||
| 1Sanofi, Barcelona, Spain, 2IMS Health, Barcelona, Spain, 3IMS Health, Madrid, Spain | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 | ||||
| Poster | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | ||
| CARDIOVASCULAR EVENT RATES IN A HIGH-RISK GENERAL POPULATION COHORT OF 340,000 INDIVIDUALS IN THE UNITED KINGDOM | ||||
| Ansell D1, Khan I2, Proudfoot C3, Gbenedio T1, Joulain F4, Pockett RD5, Catterick D3, Gooch K2 | ||||
| 1IMS Health, London, UK, 2Sanofi, Bridgewater, NJ, USA, 3Sanofi, Guildford, UK, 4Sanofi, Chilly-Mazarin, France, 5Swansea Centre for Health Economics, Swansea, UK | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 | ||||
| Poster | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Epidemiological study | |
| THE COST AND LENGTH OF STAY OF HOSPITAL EMERGENCY DEPARTMENT VISITS FOR CHRONIC HEART FAILURE PATIENTS IN CANADA | ||||
| Fischer AA1, Liu N1, Borelli R1, Zaour N2, Barbeau M2 | ||||
| 1IMS Brogan, Mississauga, ON, Canada, 2Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Cost analysis | |
| AN EPIDEMIOLOGICAL EVALUATION OF THE INCIDENCE OF DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN PATIENTS WITH HIP OR KNEE REPLACEMENT SURGERY AND OF ITS IMPACT ON THE AVERAGE LENGTH OF STAY AND HOSPITALIZATION COST | ||||
| Chevalier P, Lamotte M | ||||
| IMS Health, Vilvoorde, Belgium | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 | ||||
| Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | ||
| AN EPIDEMIOLOGICAL EVALUATION OF THE IMPACT OF PERCUTANEOUS CORONARY INTERVENTIONS ON THE HOSPITALIZATION COST, LENGTH OF STAY AND MORTALITY OF PATIENTS HOSPITALIZED WITH ACUTE CORONARY SYNDROMES | ||||
| Chevalier P, Lamotte M | ||||
| IMS Health, Vilvoorde, Belgium | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 | ||||
| Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | ||
| Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case–control study in UK general practice | ||||
| Michel A, Martin-Perez M, Ruigomez A, Garcia Rodriguez LA | ||||
| Bayer Pharma AG, Global Epidemiology | ||||
| European Journal of Heart Failure Volume 17, Issue 2, pages 205–213, February 2015 | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1002/ejhf.226/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Retrospective database analysis | |
| THE COST OF ACUTE CARE HOSPITALIZATIONS ASSOCIATED WITH CHRONIC HEART FAILURE IN CANADA | ||||
| Fischer AA1, Liu N1, Borelli R1, Barbeau M2, Zaour N2 | ||||
| 1IMS Brogan, Mississauga, ON, Canada, 2Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 | ||||
| Poster | ||||
| Canada | ||||
| Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/ispor-milan-poster.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Cost analysis | |
| Development and psychometric evaluation of a new patient-reported outcome measure for stroke self-management: The Southampton Stroke Self-Management Questionnaire (SSSMQ) | ||||
| Boger EJ1, Hankins M2, Demain SH3, Latter SM4. | ||||
| 1Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK. 2Real-World Evidence Solutions, IMS Health, London, N1 9JY, UK. 3Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK.4Faculty of Health Sciences, University of Southampton | ||||
| Health and Quality of Life Outcomes | ||||
| Article | ||||
| England | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Methodology, Oncology, Pain | 2015 | English | Database Study, Quality of life | |
| Prevention of venous thromboembolic events by fondaparinux 2.5mg in general practice. ArchiMed Ville | ||||
| Mahé I1, Daurès JP2, Pouchain D3, Quéré I4, Aubin C5, Doussaint J6, Schück S6, Leroyer C7 | ||||
| 1EA 7334 méthodologies et société (REMES), hôpital Louis-Mourier, université Paris 7, AP-HP, 178, rue des Renouillers, 92700 Colombes, France. 2IURC de Montpellier, 641, avenue du Doyen-Gaston-Giraud, 34093 Montpellier cedex, France; CHU de Nîmes, 30029 Nîmes, France. 3Département de médecine générale, UFR Tours, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France. 4Hôpital Saint-Eloi, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France. 5Laboratoire GlaxoSmithKline, 100, route de Versailles, 78160 Marly-le-roi, France. 6Kappa Santé, 4, rue de Cléry, 75002 Paris, France. 7Département de médecine interne et de pneumologie, université européenne de Bretagne, CHU de la Cavale-Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France | ||||
| J Mal Vasc. 2015 Jul 20. pii: S0398-0499(15)00121-3 | ||||
| Article | ||||
| France | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Drug Utlization Study, Orthopedics, Regulatory, Vascular disease | 2015 | English | Prospective study | |
| CARDIOVASCULAR OUTCOMES OF ANTIDIABETIC THERAPY - RESULTS OF A LITERATURE | ||||
| Greiner R, Eheberg D, Paulus G, Batscheider A | ||||
| IMS Health, Munich, Germany | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 | ||||
| Poster | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2015 | English | ||
| Cardiovascular outcomes of antidiabetics therapy-results of a literature search | ||||
| Greiner R1, Eheberg D1, Paulus G1 , Batscheider A1 | ||||
| 1 IMS Health GmbH & Co. OHG, Munich, Germany | ||||
| 18th ISPOR European Meeting, 2015 | ||||
| Poster | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Literature Review | |
| Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program | ||||
| Osborn DP, Hardoon S, Omar RZ, Holt RI | ||||
| Division of Psychiatry, UCL (University College London) | ||||
| JAMA Psychiatry. 2015 Feb;72(2):143-51. doi: 10.1001/jamapsychiatry.2014.2133. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25536289 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Mental health | 2015 | English | Retrospective database analysis | |
| Body mass index and all-cause mortality in patients with hypertension | ||||
| Xu W, Shubina M, Goldberg SI & Turchin A | ||||
| Harvard Medical School, Boston | ||||
| Obesity (Silver Spring) 23(8):1712-20 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/26179058 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Obesity | 2015 | English | Retrospective database analysis | |
| Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey | ||||
| Sabouret P1, Bricard M2, Hermann MA2, Cotté FE2, Deret-Bixio L2, Rushton-Smith S3. | ||||
| Heart Institute, Department of Cardiology, Pitié-Salpétrière Hospital, Pierre-and-Marie-Curie University, 75013 Paris, France. Electronic address: pierre.sabouret@psl.aphp.fr. 2Bristol-Myers Squibb, 92500 Rueil-Malmaison, France. 3Thrombosis Research Institute, SW3 6LR London, UK. | ||||
| Arch Cardiovasc Dis. 2015 Nov;108(11):544-53. doi: 10.1016/j.acvd.2015.05.005. Epub 2015 Jun 22. | ||||
| Article | ||||
| France | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Guidelines, Public Health | 2015 | English | Retrospective database analysis | |
| Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. | ||||
| Banefelt J1, Hallberg S2, Fox KM3, Mesterton J2,4, Paoli CJ5, Johansson G6, Levin LÅ7, Sobocki P4,8, Gandra SR5. | ||||
| 1Quantify Research, Hantverkargatan 8, 112 21, Stockholm, Sweden. jonas.banefelt@quantifyresearch.com. 2Quantify Research, Hantverkargatan 8, 112 21, Stockholm, Sweden. 3Strategic Healthcare Solutions, LLC, Baltimore, MD, USA. 4LIME/Medical Management Centre, Karolinska Institute, Stockholm, Sweden. 5Amgen Inc., Thousand Oaks, CA, USA. 6Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. 7Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 8IMS Health, Stockholm, Sweden. | ||||
| Eur J Health Econ | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://link.springer.com/article/10.1007%2Fs10198-015-0749-y | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Real World Evidence | |
| Estimating Rates of Cardiovascular Death Using Royston-Parmar Survival Models: An Example in a High Risk Patient Population in Sweden | ||||
| Julia Sandberg1, Leif Jorgensen1, Mark Danese2, Benjamin Taylor3, Ryan Kilpatrick4 and Patrik Sobocki1 | ||||
| 1 IMS Health Sweden, 2 Outcomes Insights Inc. CA USA, 3 Amgen Inc. CA USA, 4 GSK NC USA | ||||
| Circulation | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://circ.ahajournals.org/content/131/Suppl_1/AP233.abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Real World Evidence | |
| Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study | ||||
| Grundvold I1, Bodegard J2, Nilsson PM3, Svennblad B4, Johansson G5, Östgren CJ6, Sundström J7,8. | ||||
| 1Department of Cardiology, Oslo University Hospital, Ullevaal, PB 4956, Nydalen, 0424, Oslo, Norway. uxirgr@ous-hf.no. 2AstraZeneca Nordic, Södertälje, Sweden. Johan.Bodegard@astrazeneca.com. 3Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden. peter.nilsson@med.lu.se. 4Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. bodil.svennblad@ucr.uu.se. 5Department of Public health and Caring Science, Uppsala University, Uppsala, Sweden. gunnar.johansson@pubcare.uu.se. 6Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. carl.johan.ostgren@liu.se. 7Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. johan.sundstrom@medsci.uu.se. 8Department of Medical Sciences, Uppsala University, Uppsala, Sweden. johan.sundstrom@medsci.uu.se. | ||||
| Cardiovasc Diabetol | ||||
| Article | ||||
| Sweden | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299152/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2015 | English | Real World Evidence | |
| Clinical attributes, treatment, and control in hypertension (CATCH)-a French and Italian longitudinal patient database study | ||||
| Wu D1, Mansoor G2, Kempf C3. | ||||
| 1Merck &Co., Inc., Kenilworth, NJ USA ; Global Health Outcomes, Merck & Co., Inc., 600 Corporate Drive, CRB-205, Cokesbury, NJ 08833 USA. 2Merck &Co., Inc., Kenilworth, NJ USA. 3Cegedim Strategic Data, Paris, France. | ||||
| Clin Hypertens. 2015 Aug 10;21:18 | ||||
| Article | ||||
| France, Italy | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750805/pdf/40885_2015_Article_29.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Retrospective database analysis | |
| Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case–control study in UK general practice | ||||
| Michel A, Martín-Pérez M, Ruigómez A, García Rodríguez LA | ||||
| Bayer Pharma; Spanish Centre for Pharmacoepidemiologic Research (CEIFE) | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Retrospective database analysis | |
| Methods of defining hypertension in electronic medical records: validation against national survey data | ||||
| Peng M, Chen G, Kaplan GG, Lix LM, Drummond N, Lucyk K, Garies S, Lowerison M, Weibe S, Quan H | ||||
| Department of Community Health Sciences, University of Calgary; Alberta Health Service, Calgary; Department of Medicine, University of Calgary; Department of Community Health Sciences, University of Manitoba; Department of Family Medicine, University of Alberta; Department of Family Medicine, University of Calgary; Cumming School of Medicine, University of Calgary; Departments of Clinical Neurosciences, University of Calgary | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Retrospective database analysis | |
| Diabetes, Cardiovascular Morbidity, and Risk of Age-Related Macular Degeneration in a Primary Care Population | ||||
| Vassilev ZP, Ruigómez A, Soriano-Gabarró M, García Rodríguez LA | ||||
| Bayer Pharma; Spanish Centre for Pharmacoepidemiologic Research (CEIFE) | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes, Miscellaneous, Ophthalmology | 2015 | English | Retrospective database analysis | |
| Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study | ||||
| Xu W, Goldberg SI, Shubina M, Turchin A | ||||
| Department of Medicine, Beth Israel Deaconess Medical Centre; Department of Radiation Oncology, Massachusetts General Hospital; Division of Endocrinology, Brigham and Women's Hospital | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2015 | English | Retrospective database analysis | |
| Cost-Effectiveness of Rivaroxaban for the Treatment of Pulmonary Embolism in Canada | ||||
| Levac B1, Marrie J1, Chin W2, Hassan F3, Bamber L4, McLeod EJ3 | ||||
| 1Bayer Inc., ON, Canada, 2ILEX Consulting Inc., ON, Canada, 3IMS Health, United Kingdom, 4Bayer Healthcare, Germany | ||||
| ISPOR, 19th Annual International Meeting, Montreal, Canada, May 31 - June 4th 2014 - PCV90 Value in Health, 2014, 17(3): A117-A118 |
||||
| Poster | ||||
| Canada | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)00735-9/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Cost effectiveness | |
| Non-adherence to antiplatelet therapy after hospitalization for acute coronary syndrome (ACS) increases readmissions, mortality, health care use and costs. | ||||
| Hill J1, Pokras S2, Foody J3, Schabert V4, Makin C5, Nelson M2 | ||||
| 1 IMS Health, Plymouth Meeting, USA 2 IMS Health, Alexandria, USA 3 Brigham and Women’s Hospital, Boston, USA 4 IMS Health, Woodland Hills, USA, 5 IMS Health, Falls Church, USA | ||||
| International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual International Meeting, 2014, May, Montreal, Canada | ||||
| Podium presentation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Retrospective database analysis | |
| Description of Cardiovascular Event Rates in Patients Initiating Chronic Opioid Therapy for Noncancer Pain in Observational Cohort Studies in the US, UK, and Germany | ||||
| LoCasale R1, Kern DM2, Chevalier P3, Zhou S2, Chavoshi S1, Sostek M | ||||
| 1 AstraZeneca, Wilmington Delaware, USA 2 HealthCore Inc., Wilmington Delaware, USA 3 IMS Health, Vilvoorde, Belgium | ||||
| Adv Ther. 2014 Jul;31(7):708-23 | ||||
| Manuscript in preparation | ||||
| Germany, UK, USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Pain | 2014 | English | Epidemiological study, Retrospective database analysis | |
| Cost of a pulmonary arterial hypertension-related hospitalization in Belgium | ||||
| Chevalier P1, De Beule J2, Lamotte M1, Hunsche E2, Regulier E2 | ||||
| 1IMS Health, Vilvoorde,Belgium, 2Actelion Pharmaceuticals Ltd., Allschwil, Switzerland | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands | ||||
| Abstract | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Retrospective database analysis | |
| The cost-effectiveness of dabigatran etexilate compared with rivaroxaban in the treatment of acute venous thromboembolism in the UK | ||||
| Jugrin A1, Ustyugova A2, Urbich M3, Lamotte M1, Sunderland T3 | ||||
| 1IMS HEOR, Vilvoorde, Belgium, 2 Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany, 3 Boehringer Ingelheim Ltd, Bracknell, UK | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands | ||||
| Poster | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Cost effectiveness, Cost utility | |
| Impact of a pharmacological cardioversion with vernakalant on the management cost of recent atrial fibrillation in Belgium. | ||||
| Lamotte M1, Gerlier L1, Caekelbergh K1, Polifka J2, Lalji K2, Lee E2 | ||||
| 1 IMS Health, Vilvoorde, Belgium 2 Cardiome, Vancouver, Canada | ||||
| ISPOR 17th Annual European Congress, 8-12 November, Amsterdam, The Netherlands | ||||
| Abstract, Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Budget impact, Cost minimization | |
| Potential Signals for Cardiovascular-Related Adverse Events with COX Inhibitor Use: Analysis of the WHO Global ICSR Database System (VigiBase) | ||||
| Prieto-Merino D1, Kim J2, Evans SJW1 | ||||
| 1 London School of Hygiene & Tropical Medicine, London, UK 2 IMS Health, London, UK | ||||
| Pharmacoepidemiology & Therapeutic Risk Management (ICPE), October 24-27, 2014 at the Taipei International Convention Center. | ||||
| Poster | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Epidemiological study | |
| Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting | ||||
| Morais J1, Aguiar C2, McLeod E3, Chatzitheofilou I3, Fonseca Santos I4, Pereira S4 | ||||
| 1 Hospital de Santo André, CHLP, Leiria, Portugal 2 Hospital de Santa Cruz, CHLO, Carnaxide, Portugal 3 IMS Health, London, UK 4 Bayer Portugal, S.A., Carnaxide, Portugal | ||||
| Portuguese Journal of Cardiology, In Press | ||||
| Article | ||||
| Portugal | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Cost effectiveness | |
| Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia - estimates from population-based register data in Sweden | ||||
| Banefelt J1, Hallberg S1, Fox KM2, Mesterton J1, Paoli CJ3, Johansson G4, Levin L5, Sobocki P6, Gandra SR3 | ||||
| 1Quantify Research, Stockholm, Sweden, 2Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 3Amgen, Inc., Thousand Oaks, CA, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
| ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014 | ||||
| Podium presentation | ||||
| Sweden | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Cost of illness | |
| A retrospective study of mortality in risk patients with high dose statin usage and no statin usage | ||||
| Rockberg J1, Jørgensen L1, Taylor B2, Kilpatrick RD2, Sobocki P1 | ||||
| 1Pygargus/IMS Health, Stockholm, Sweden, 2Amgen Inc, Thousand Oaks, CA, USA | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands | ||||
| Poster | ||||
| Sweden | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Retrospective database analysis | |
| Burden of hyperlipidemia resulting from productivity loss - estimates from population-based register data in Sweden | ||||
| Banefelt J1, Hallberg S1, Gandra SR2, Mesterton J1, Fox KM3, Paoli CJ2, Johansson G4, Levin L5, Sobocki P6 | ||||
| Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
| ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014 | ||||
| Poster | ||||
| Sweden | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Burden of illness | |
| Healthcare costs associated with cardiovascular events in patients with hyperlipidemia - estimates from population-based register data in Sweden | ||||
| Hallberg S1, Banefelt J1, Mesterton J1, Gandra SR2, Fox KM3, Johansson G4, Levin L5, Sobocki P6 | ||||
| 1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands | ||||
| Poster | ||||
| Sweden | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Cost of illness, Population Based Study | |
| LDL-C goal attainment in patients with hyperlipidemia - estimates from population-based register data in Sweden | ||||
| Mesterton J1, Hallberg S1, Gandra SR2, Banefelt J1, Fox KM3, Johansson G4, Levin L5, Sobocki P6 | ||||
| Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands | ||||
| Poster | ||||
| Sweden | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Population Based Study | |
| Comparing quality effects of patient care in integrated and regular care for patients with hypertension | ||||
| Waehlert L1, Rex J2, Engelhard J2, Altmann V2, Kostev K2 | ||||
| 1Fresenius University of applied sciences, Idstein, Germany, 2IMS Health, Frankfurt am Main, Germany | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands | ||||
| Poster | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Database Study | |
| Treatment patterns in hyperlipidemia patients with new cardiovascular events - estimates from population-based register data in Sweden | ||||
| Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1, Johansson G3, Levin L4, Sobocki P5, Gandra SR6 | ||||
| 1Quantify Research, Stockholm, Sweden, 2Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 3Uppsala University, Uppsala, Sweden, 4Linköping University, Linköping, Sweden, 5IMS Health, Stockholm, Sweden, 6Amgen, Inc., Thousand Oaks, CA, USA | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands | ||||
| Poster | ||||
| Sweden | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Database Study | |
| Healthcare costs associated with cardiovascular events in patients with hyperlipidemia - estimates from population-based register data in Sweden | ||||
| Hallberg S1, Banefelt J1, Mesterton J1, Gandra SR2, Fox KM3, Johansson G4, Levin L5, Sobocki P6 | ||||
| 1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands | ||||
| Poster | ||||
| Sweden | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Population Based Study | |
| Cardiovascular risk and lifestyle habits of consumers of a phytosterol-enriched yogurt in a real-life setting. | ||||
| Paillard F1, Bruckert E2, Naelten G3, Picard P4, van Ganse E5. | ||||
| 1Cardiovascular Prevention Center, CHU Pontchaillou, Rennes, France. 2Service Endocrinologie et Prévention des Maladies Cardiovasculaires, Hôpital Pitié Salpêtrière, Paris, France. 3Danone Research, Palaiseau, France. 4Aixial Pharma, Levallois Perret, France. 5Pharmacoepidemiology, UMR CNRS 5558, Claude-Bernard Lyon 1 University, Lyon, France. | ||||
| J Hum Nutr Diet. 2014 Apr 19. doi: 10.1111/jhn.12236 | ||||
| Article | ||||
| France | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24750351 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Nutritional Disorders | 2014 | English | Prospective study, Retrospective database analysis | |
| C-reactive protein levels in patients at cardiovascular risk: EURIKA study. | ||||
| Halcox JP, Roy C, Tubach F, Banegas JR, Dallongeville J, De Backer G, Guallar E, Sazova O, Medina J, Perk J, Steg PG, Rodríguez-Artalejo F, Borghi C. | ||||
| BMC Cardiovascular Disorders 2014, 14:25 doi:10.1186/1471-2261-14-25 | ||||
| Article | ||||
| Europe | ||||
| Abstract: http://www.biomedcentral.com/1471-2261/14/25 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Prospective study | |
| Effect of psoriasis severity on hypertension control: a population-based study in the United kingdom. | ||||
| Takeshita J, Wang S, Shin DB, Mehta NN, Kimmel SE, Margolis DJ, Troxel AB & Gelfand JM | ||||
| University of Pennsylvania Department of Dermatology | ||||
| JAMA Dermatol. 2015 Feb 1;151(2):161-9. doi: 10.1001/jamadermatol.2014.2094 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25322196 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Dermatology | 2014 | English | Retrospective database analysis | |
| High performance of a risk calculator that includes renal function in predicting mortality of hypertensive patients in clinical application. | ||||
| Ravera M1, Cannavò R1, Noberasco G2, Guasconi A3, Cabib U1, Pieracci L1, Pegoraro V3, Brignoli O2, Cricelli C2, Deferrari G1, Paoletti E1. | ||||
| 1 Division of Nephrology, Dialysis and Transplantation, University of Genoa IRCCS - Azienda Ospedaliera Universitaria San Martino - IST - Genoa 2 Italian College of General Practitioners (SIMG), Florence, 3 Cegedim Strategic Data Medical Research, Milan, Italy. | ||||
| J Hypertens. 2014 Jun;32(6):1245-54. doi: 10.1097/HJH.0000000000000177 | ||||
| Article | ||||
| Italy, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24751593 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Nephrology | 2014 | English | Retrospective database analysis | |
| Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation. | ||||
| Misra D, Zhang Y, Peloquin C, Choi HK, Kiel DP & Neogi T | ||||
| Boston University School of Medicine | ||||
| Osteoporos Int. 2014 Jun;25(6):1677-84. doi: 10.1007/s00198-014-2662-0. Epub 2014 Mar 29 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24833176 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Orthopedics | 2014 | English | Retrospective database analysis | |
| Increased Risk of Acute Cardiovascular Events After Partner Bereavement: A Matched Cohort Study. | ||||
| Carey IM, Shah SM, Dewilde S & et al | ||||
| St George's University of London Division of Population Health Sciences and Education | ||||
| JAMA Intern Med. February 24, 2014. doi:10.1001/jamainternmed.2013.14558 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.epccs.eu/d/287/more-major-cv-events-in-months-after-loss-of-partner | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Mental health | 2014 | English | Retrospective database analysis | |
| Low-Dose Aspirin and Upper Gastrointestinal Bleeding in Primary Versus Secondary Cardiovascular Prevention: A Population-Based, Nested Case-Control Study. | ||||
| Lin KJ, De Caterina R & Rodríguez LA | ||||
| Harvard School of Public Health Department of Epidemiology | ||||
| Circulation: Cardiovascular Quality and Outcomes 1;7(1):70-7 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://circoutcomes.ahajournals.org/content/7/1/70 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Gastrointestinal disorders | 2014 | English | Retrospective database analysis | |
| Prescription of antihypertensive medications during pregnancy in the UK | ||||
| Cea Soriano L, Bateman BT, García Rodríguez LA & Hernández-Díaz S | ||||
| Spanish Centre for Pharmacoepidemiologic Research (CEIFE); Harvard School of Public Health Department of Epidemiology | ||||
| Pharmacoepidemiology and Drug Safety Volume 23, Issue 10, pages 1051–1058, October 2014 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1002/pds.3641/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Womens Health | 2014 | English | Retrospective database analysis | |
| Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA study. | ||||
| Moses Elisaf1, Emmanouil Tzouvelekis2, Nikos Nikas2; on behalf of the Greek EURIKA Investigators | ||||
| 1 Department of Internal Medicine, University Hospital of Ioannina, Ioannina, 2 Medical Department, AstraZeneca SA, Athens, Greece | ||||
| Hellenic J Cardiol. 2014 May-Jun;55(3):217-26 | ||||
| Article | ||||
| Greece | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24862614 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Survey research | |
| Renal function, attributes and coagulation treatment in atrial fibrillation (R-FACT Study): retrospective, observational, longitudinal cohort study of renal function and antithrombotic treatment patterns in atrial fibrillation patients with documented eGFR in real-world clinical practices in Germany. | ||||
| D. Wu1, G. Mansoor2, C. Kempf3, M.-S. Schwalm4 andJ. Chin4 | ||||
| 1Global Health Outcomes, Merck & Co., Inc., Whitehouse Station, NJ, USA 2Clinical Research, Merck & Co., Inc., Whitehouse Station, NJ, USA 3Cegedim Strategic Data, Paris, France 4Cegedim Strategic Data, Jersey City, NJ, USA | ||||
| Int J Clin Pract. 2014 Jun;68(6):714-24 | ||||
| Article | ||||
| Germany | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24499317 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Nephrology | 2014 | English | Retrospective database analysis | |
| Represcription of low-dose acetylsalicylic acid after discontinuation in patients receiving treatment for secondary cardiovascular disease prevention in the UK. | ||||
| Martín-Merino E, Johansson S, Nagy P & Rodríguez LA | ||||
| Spanish Centre for Pharmacoepidemiologic Research (CEIFE) | ||||
| Am J Cardiovasc Drugs. 2014 Aug;14(4):319-26. doi: 10.1007/s40256-014-0079-y. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25027353 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Retrospective database analysis | |
| Retrospective case review of missed opportunities for primary prevention of stroke and TIA in primary care: protocol paper. | ||||
| Moran GM, Calvert M, Feltham MG & Marshall T | ||||
| University of Birmingham Primary Care Clinical Sciences | ||||
| BMJ Open2014;4:e006622 doi:10.1136/bmjopen-2014-006622 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://bmjopen.bmj.com/content/4/11/e006622.full | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Neurological disorders | 2014 | English | Retrospective database analysis | |
| Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database. | ||||
| Sabouret P1, Depret-Bixio L, Cotte FE, Marie P, Bedira N, Blin P. | ||||
| 1Department of Cardiology, Pitié Salpétrière Hospital, Heart Institute, Pierre and Marie Curie University, Paris, France | ||||
| Clin Res Cardiol. 2014 Nov;103(11):887-93. doi: 10.1007/s00392-014-0726-y. Epub 2014 May 15 | ||||
| Article | ||||
| France | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24830515 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Retrospective database analysis | |
| Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countries. | ||||
| Cotté FE1, Benhaddi H2, Duprat-Lomon I2, Doble A3, Marchant N4, Letierce A5, Huguet M5. | ||||
| Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France. Electronic address: francois-emery.cotte@bms.com. 2Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France. 3Foxymed, Paris, France. 4Pfizer, Walton Oaks, United Kingdom. 5Cegedim Strategic Data, Boulogne-Billancourt, France | ||||
| Clin Ther. 2014 Sep 1;36(9):1160-8. doi: 10.1016/j.clinthera.2014.07.016. Epub 2014 Aug 21. | ||||
| Article | ||||
| France, Germany, Italy, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25151574 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Retrospective database analysis | |
| Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. | ||||
| Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, Troxel AB, Hennessy S, Kimmel SE, Margolis DJ, Choi H, Mehta NN & Gelfand JM | ||||
| University of Pennsylvania Division of Rheumatology | ||||
| Ann Rheum Dis. 2015 Feb;74(2):326-32. doi: 10.1136/annrheumdis-2014-205675. Epub 2014 Oct 28 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25351522 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Rheumatology | 2014 | English | Retrospective database analysis | |
| Availability and quality of coronary heart disease family history in primary care medical records: implications for cardiovascular risk assessment | ||||
| Dhiman P, Kai J, Horsfall L, Walters K & Qureshi N | ||||
| University of Nottingham School of Medicine, Division of Primary Care | ||||
| PLoS One. 2014 Jan 9;9(1):e81998. doi: 10.1371/journal.pone.0081998. eCollection 2014 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886986/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Retrospective database analysis | |
| Global cardiovascular risk evaluation: pattern of algorithm use and risk modification in real life | ||||
| Filippi A1, Giampaoli S, Lapi F, Mazzaglia G, Palmieri L, Pecchioli S, Brignoli O, Cricelli C, Simonetti M, Sessa E, Marchioli R. | ||||
| 1aItalian College of General Practitioners, Florence bNational Institute of Health, Rome cHealth Search, Italian College of General Practitioners dRegional Agency for Healthcare Services of Tuscany, Florence eConsorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy | ||||
| J Cardiovasc Med, Epub 2014 | ||||
| Abstract | ||||
| Italy | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Retrospective database analysis | |
| Effects of a computerized decision support system in improving pharmacological management in high-risk cardiovascular patients: A cluster-randomized open-label controlled trial | ||||
| Mazzaglia G1, Piccinni C2, Filippi A1, Sini G1, Lapi F1, Sessa E1, Cricelli I1, Cutroneo P3, Trifirò G4, Cricelli C1, Caputi AP3 | ||||
| 1Italian College of General Practitioners, Italy.2University of Bologna, Italy.3University of Messina, Italy. 4University of Messina, Italy; Erasmus University Medical Center, The Netherlands. | ||||
| Health Informatics Journal, Epub 2014 Sep 10 | ||||
| Abstract | ||||
| Italy | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Methodology | 2014 | English | Retrospective database analysis | |
| Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK. | ||||
| Breuer J, Pacou M, Gauthier A & Brown MM | ||||
| UCL From the Division of Infection and Immunity | ||||
| Neurology. 2014 Jan 21; 82(3): 206–212. doi: 10.1212/WNL.0000000000000038 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902756/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Infectious disease, Neurological disorders, Vascular disease | 2014 | English | Retrospective database analysis | |
| Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study | ||||
| Karch A & Thomas SL | ||||
| Department of Epidemiology (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Faculty of Epidemiology & Population Health (A.K., S.L.T.), London School of Hygiene and Tropical Medicine, UK; and Department of Neurology (A.K.), University Medical Center Göttingen, Germany. | ||||
| Neurology. 2014 May 6;82(18):1643-52. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24719488 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Endocrinology, Immunology and Vaccination, Neurological disorders | 2014 | English | Retrospective database analysis | |
| Understanding Real Life Treatment Patterns among Patients with Hypertension: A Markov Model. | ||||
| Alexia LETIERCE, Emmanuelle BOUTMY and Laurence Sophie JOUAVILLE | ||||
| Cegedim Strategic Data, Boulogne-Billancourt, France | ||||
| ISPOR 17th Annual European Congress 8-12 November 2014 Amsterdam RAI Amsterdam, The Netherlands | ||||
| Poster | ||||
| France | ||||
| Abstract: http://www.ispor.org/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Longitudinal study, Retrospective database analysis | |
| The burden of preserved ejection fraction heart failure in a real-world Swedish patient Population | ||||
| Stålhammar Ja, Stern Lb, Linder Rc, Sherman Sb, Parikh Rb, Ariely Rd, Deschaseaux Ce, Wikström Ga. | ||||
| a Uppsala University Uppsala Sweden b LA-SER Analytica New York, NY USA c Pygargus AB Stockholm Sweden d GlaxoSmithKline, Inc. Clifton, NJ USA e Novartis, Inc. Basel Switzerland | ||||
| J Med Econ | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://www.tandfonline.com/doi/full/10.3111/13696998.2013.848808 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Real World Evidence | |
| Burden Of Hyperlipidemia Resulting From Productivity Loss - Estimates From Population-Based Register Data In Sweden | ||||
| Banefelt J.1, Hallberg S.1, Gandra S.R.2, Mesterton J.1, Fox K.M.3, Paoli C.J.2, Johansson G.4, Levin L.Å.5, Sobocki P.6 | ||||
| 1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
| Value in Health | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)03384-1/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Real World Evidence | |
| LDL-C GOAL ATTAINMENT IN PATIENTS WITH HYPERLIPIDEMIA - ESTIMATES FROM POPULATION-BASED REGISTER DATA IN SWEDEN | ||||
| Mesterton J1, Hallberg S1, Gandra SR2, Banefelt J1, Fox KM3, Johansson G4, Levin L5, Sobocki P6 | ||||
| 1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
| ISPOR 17th Annual European Congress Amsterdam, The Netherlands November, 2014 | ||||
| Abstract | ||||
| Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Real World Evidence | |
| TREATMENT PATTERNS IN HYPERLIPIDEMIA PATIENTS WITH NEW CARDIOVASCULAR EVENTS - ESTIMATES FROM POPULATION-BASED REGISTER DATA IN SWEDEN | ||||
| Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1, Johansson G3, Levin L4, Sobocki P5, Gandra SR6 | ||||
| 1Quantify Research, Stockholm, Sweden, 2Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 3Uppsala University, Uppsala, Sweden, 4Linköping University, Linköping, Sweden, 5IMS Health, Stockholm, Sweden, 6Amgen, Inc., Thousand Oaks, CA, USA | ||||
| ISPOR 17th Annual European Congress Amsterdam, The Netherlands November, 2014 | ||||
| Abstract, Poster | ||||
| Sweden | ||||
| Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Real World Evidence | |
| HEALTH CARE COSTS ASSOCIATED WITH CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERLIPIDEMIA - ESTIMATES FROM POPULATION-BASED REGISTER DATA IN SWEDEN | ||||
| Hallberg S1, Banefelt J1, Mesterton J1, Gandra SR2, Fox KM3, Johansson G4, Levin L5, Sobocki P6 | ||||
| 1Quantify Research, Stockholm, Sweden, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4Uppsala University, Uppsala, Sweden, 5Linköping University, Linköping, Sweden, 6IMS Health, Stockholm, Sweden | ||||
| ISPOR 17th Annual European Congress Amsterdam, The Netherlands November, 2014 | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Real World Evidence | |
| A RETROSPECTIVE STUDY OF MORTALITY IN RISK PATIENTS WITH HIGH DOSE STATIN USAGE AND NO STATIN USAGE | ||||
| Rockberg J1, Jørgensen L1, Taylor B2, Kilpatrick RD2, Sobocki P1 | ||||
| 1Pygargus/IMS Health, Stockholm, Sweden, 2Amgen Inc, Thousand Oaks, CA, USA | ||||
| Sweden | ||||
| Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Real World Evidence | |
| ASEAN Heart J | ||||
| Lansang EZ, Horsburgh D, Lee YN, Sng A, Moussalli R, Wai K, Anand I, Zhang S, Shimizu W, Narasimhan C, Park SW, Yu C, Ngarmukos T, Omar R, Reyes EB, Siswanto BB, Richards AM, Lam CSP | ||||
| Implications for Resource Allocation, Preventive Strategies and Clinical Trial Design | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Physicians’ Perception of the Patient Care Pathway for Acute Heart Failure in Asian Countries: Implications for Resource Allocation, Preventive Strategies and Clinical Trial Design | ||||
| Lansang EZ, Horsburgh D, Lee YN, Sng A, Moussalli R, Wai K, Anand I, Zhang S, Shimizu W, Narasimhan C, Park SW, Yu C, Ngarmukos T, Omar R, Reyes EB, Siswanto BB, Richards AM, Lam CSP | ||||
| ASEAN Heart J. 2014; 22(1), 99 – 111 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Impact of the ENHANCE Trial on the use of ezetimibe in the United States and Canada | ||||
| Lu L, Krumholz HM, Tu JV, Ross JS, Ko DT, Jackevicius CA | ||||
| 1Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA. | ||||
| American Heart Journal 2014;167(5):683-689. | ||||
| Abstract | ||||
| Abstract: http://www.sciencedirect.com/science/article/pii/S0002870314000866 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2014 | English | Public Health | |
| Renal function, attributes and coagulation treatment in atrial fibrillation (R-FACT Study): retrospective, observational, longitudinal cohort study of renal function and antithrombotic treatment patterns in atrial fibrillation patients with documented eGFR in real-world clinical practices in Germany. | ||||
| Wu D1, Mansoor G, Kempf C2, Schwalm MS2, Chin J. | ||||
| 1Global Health Outcomes, Merck & Co., Inc., Whitehouse Station, NJ, USA. 2 Cegedim strategic Data | ||||
| Int J Clin Pract. 2014 Jun;68(6):714-24. | ||||
| Article | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Nephrology | 2014 | English | Retrospective database analysis | |
| Treatment cost of acute coronary syndrome with ticagrelor compared to clopidogrel in Switzerland. | ||||
| Gasche D1, Ulle T2, Meier B3, Greiner RA1 | ||||
| 1 IMS Health, Munich, Germany 2 AstraZeneca AG, Zug, Switzerland 3 Department of Cardiology, Bern University Hospital, Bern, Switzerland | ||||
| Gemeinsamen Jahrestagung der Schweizerischen Gesellschaften für Kardiologie und der Schweizerischen Gesellschaft für Herz- und Thorakale Gefässchirurgie - in press, 2013. | ||||
| Poster | ||||
| Switzerland | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Cost analysis | |
| Assessing the consistency of absolute cardiovascular risk prediction and relative risk reduction in type-2 diabetes mellitus | ||||
| McEwan P1;Lamotte M2;Grant D3;Palmer JL4;Lloyd A3, Foos V5 | ||||
| 1Swansea University, Cardiff, United Kingdom, 2IMS Health, Vilvoorde, Belgium, 3IMS Health, London, United Kingdom, 4IMS Health, Allschwil, Basel-Landschaft, Switzerland, 5IMS Health, Basel, Switzerland | ||||
| ISPOR 18th Annual International Meeting, May 18-22, 2013 New Orleans, LA, USA. | ||||
| Poster | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2013 | English | Quality of life | |
| Dabigatran Etexilate is Associated with Shorter Hospital Length of Stay and Lower Hospital Costs Compared to Warfarin in Treatment-Naïve, Newly-Diagnosed Non-Valvular Atrial Fibrillation Patients | ||||
| Fonseca E1, Walker DR2, Hess G1 | ||||
| 1IMS Health, Plymouth Meeting, USA 2 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, USA | ||||
| AHA QCOR Cardiovascular Disease and Stroke 2013 Scientific Conference. Baltimore, MD, May 15-17, 2013 | ||||
| Poster | ||||
| USA | ||||
| Abstract: http://circoutcomes.ahajournals.org/cgi/content/meeting_abstract/6/3_MeetingAbstracts/A258 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Cost benefit | |
| Non-Valvular Atrial Fibrillation Emergency Department Encounters where Dabigatran Etexilate was Administered are Associated with Lower Admission Rate Compared to Encounters where Warfarin was Administered. | ||||
| Fonseca E1, Walker DR2, Hess G1 | ||||
| 1 IMS Health, Plymouth Meeting, USA 2 Boehringer Ingelheim Pharmaceuticals, Ridgefield, USA | ||||
| American Heart Association (AHA) Quality of Care and Outcomes Research (QCOR) Cardiovascular Disease and Stroke 2013 Scientific Conference. Baltimore, MD, May 15-17, 2013 | ||||
| Poster | ||||
| USA | ||||
| Abstract: http://circoutcomes.ahajournals.org/cgi/content/meeting_abstract/6/3_MeetingAbstracts/A95 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Cost benefit | |
| Use of Hospital Claim Data to Estimate the Clinical and Economic Burden of ACS Re-Hospitalizations in Real-World Clinical Practice | ||||
| Hess, GP1, Bhandary MS2, Gandhi S2, Kumar D1, Fonseca E1, Gold A2 | ||||
| 1 IMS Health, Plymouth Meeting, USA 2 AstraZeneca Pharmaceuticals LP, Wilmington, USA | ||||
| AHA QCOR Cardiovascular Disease and Stroke 2011 Scientific Conference. Washington, DC, May 12-14, 2011 | ||||
| Poster | ||||
| USA | ||||
| Abstract: http://circoutcomes.ahajournals.org/cgi/content/meeting_abstract/4/6_MeetingAbstracts2011/AP11 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Cost consequence | |
| Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting | ||||
| Kleintjens J1, Li X1, Simoens S2, Thijs V3, Goethals M4, Rietzschel ER5, Asukai Y6, Saka O1, Evers T7, Faes P8, Vansieleghem S8, De Ruyck M8 | ||||
| 1Deloitte Health Economics and Outcomes Research Group, Brussels, Belgium, 2Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium, 3Department of Neurology, University Hospitals Leuven, Leuven,Belgium, 4Mariaziekenhuis Noord-Limburg, Overpelt, Belgium, 5Department of Public Health, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, Belgium, 6IMS Health, London, UK, 7Global Market Access/HEOR, Bayer HealthCare, Wuppertal, Germany, 8Market Access Department, Bayer HealthCare, J.E. Mommaertslaan 14, 1831 Diegem (Machelen), Belgium | ||||
| PharmacoEconomics DOI 10.1007/s40273-013-0087-9 | ||||
| Article | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Cost effectiveness | |
| Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients. | ||||
| Sundström J, Sheikhi R, Ostgren CJ, Svennblad B, Bodegård J, Nilsson PM, Johansson G. | ||||
| IMS Health (Formally Pygargus) | ||||
| J Hypertens. 2013 Aug;31(8):1603-10 | ||||
| Abstract, Article | ||||
| Sweden | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23625112 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2013 | English | Retrospective cohort analysis | |
| Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care. | ||||
| Östgren CJ, Sundström J, Svennblad B, Lohm L, Nilsson PM, Johansson G. | ||||
| IMS Health, Stockholm, Sweden (Formally Pygargus) | ||||
| Diabet Med. 2013 May;30(5):e170-7 | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23350893 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2013 | English | Retrospective cohort analysis | |
| Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study. | ||||
| Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G. | ||||
| IMS Health, Stockholm, Sweden (Formally Pygargus) | ||||
| J Intern Med. 2013 Jun;273(6):584-94 | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23495860 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective cohort analysis | |
| Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS) | ||||
| Christer Janson1, Kjell Larsson2,Karin H Lisspers3, Björn Ställberg3, Georgios Stratelis4, Helena Goike4, Leif Jörgensen4, Gunnar Johansson5 | ||||
| 1Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, Sweden, 2Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institute, Stockholm, 3Department of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden, 4AstraZeneca Nordic, Södertälje, Sweden, 5IMS Health, Stockholm (Formally Pygargus) | ||||
| BMJ 2013;346:f3306. Doi: 10.1136/bmj.f3306 | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://www.bmj.com/content/346/bmj.f3306 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Observational study, Retrospective cohort analysis | |
| Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8,486 primary care patients | ||||
| Bodegard J, Sundström J, Svennblad B, Östgren CJ, Nilsson PM, Johansson G | ||||
| IMS Health, Stockholm, Sweden (Formally Pygargus) | ||||
| Diabetes Metab. 2013 Sep;39(4):306-13 | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23871502 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2013 | English | Retrospective cohort analysis | |
| A New Method To Get Fast Patient Reported Outcomes Data from Primary Care in the UK for Patients with Atrial Fibrillation (AF) in the Health Improvement Network (THIN). | ||||
| Johnson M, Vial D, Thompson M, Cockbain C, Hogan S, Bourke A | ||||
| Cegedim | ||||
| 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Montreal, Canada | ||||
| Poster | ||||
| UK | ||||
| Abstract: http://www.pharmacoepi.org/pub/09DDEEBB-9ECC-7DB3-89E5-8C1F5B93B016 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| ADHERENCE TO TREATMENT AND PERSISTENCY IN PATIENTS TREATED WITH VKA IN FRANCE, ITALY, GERMANY, SPAIN AND UK | ||||
| COTTÉ FE1, CARRASCO J1, DUPRATLOMON I1, MARCHANT N2, LETIERCE A3 & HUGUET M3 | ||||
| (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
| ISPOR Annual European Congress, Dublin. 2013. | ||||
| Poster | ||||
| France, Germany, Italy, Spain, UK | ||||
| Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| Anticoagulation treatment with VKA in France, Italy, Germany, Spain and UK. Results from the REACT-AF study. | ||||
| COTTÉ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M | ||||
| (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
| ISPOR Annual European Congress, Dublin. 2013 | ||||
| Poster | ||||
| France, Germany, Italy, Spain, UK | ||||
| Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| Antithrombotic drugs and risk of hemorrhagic stroke in the general population. | ||||
| García-Rodríguez LA, Gaist D, Morton J, Cookson C & González-Pérez A | ||||
| Spanish Centre for Pharmacoepidemiological Research (CEIFE) | ||||
| Neurology. 2013 Aug 6;81(6):566-74. doi: 10.1212/WNL.0b013e31829e6ffa. Epub 2013 Jul 10. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23843464 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Hematology | 2013 | English | Retrospective database analysis | |
| Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at Very High Cardiovascular Risk in the United Kingdom: Results from a General Practice Population Study. | ||||
| Ray K, Foody J, Khan I, Gorcyca K, Ansell D & Lewis B | ||||
| IMS health | ||||
| 16th Annual European ISPOR Congress
http://dx.doi.org/10.1016/j.jval.2013.08.1208 Dublin, Ireland |
||||
| Poster | ||||
| UK | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03113-6/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| C-reactive protein distribution and correlation with traditional cardiovascular risk factors in the Italian population. | ||||
| Casula M, Tragni E, Zambon A, Filippi A, Brignoli O, Cricelli C, Poli A, Catapano AL; CHECK group. | ||||
| Epidemiology and Preventive Pharmacology Centre (SEFAP), Department of Pharmacological Sciences, University of Milan,Italy | ||||
| Eur J Intern Med. 2013 Mar;24(2):161-6. doi: 10.1016/j.ejim.2012.09.010. Epub 2012 Oct 4. | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23040261 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Epidemiological study | |
| Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care. | ||||
| Martín Merino E, Johansson S, Nagy P & García Rodríguez LA | ||||
| Spanish Centre for Pharmacoepidemiological Research (CEIFE) | ||||
| Am J Cardiol. 2013 Oct 15;112(8):1075-82. doi: 10.1016/j.amjcard.2013.05.051. Epub 2013 Jul 4. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23831164 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries | ||||
| Coloma PM, Valhoff VE, Mazzaglia G, Nielsson MS, Pedersen L, Molokhia M, Mosseveld M, Morabito P, Schuemie MJ, Van Der Lei J, Sturkenboom M, Trifiro G, EU-ADR Consortium. | ||||
| Department of Medical Informatics, Erasmus MC University Medical Center, Rotterdam, The Netherlands. | ||||
| BMJ Open2013;3:e002862 doi:10.1136/bmjopen-2013-002862 | ||||
| Article | ||||
| Europe, Italy | ||||
| Abstract: http://bmjopen.bmj.com/content/3/6/e002862.abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Methodology | 2013 | English | Retrospective database analysis | |
| Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care. | ||||
| Ravera M1, Noberasco G, Signori A, Re M, Filippi A, Cannavò R, Weiss U, Cricelli C, Deferrari G, Paoletti E. | ||||
| 1Division of Nephrology, Dialysis and Transplantation, Department of Internal Medicine, University of Genoa, IRCCS-Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy. | ||||
| Am J Hypertens. 2013 May;26(5):700-7. doi: 10.1093/ajh/hps100. Epub 2013 Jan 28. | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23391620 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Nephrology | 2013 | English | Retrospective database analysis | |
| Modélisation des changements de traitement antihypertenseurs en France à l'aide de chaines de Markov. | ||||
| LETIERCE A, KEMPF C | ||||
| Cegedim Strategic Data, Boulogne-Billancourt, France | ||||
| 7ème Conférence Francophone d'Epidémiologie Clinique, / 6è FORUM SCIENTIFIQUE DE PHARMACO-EPIDEMIOLOGIE | ||||
| Poster | ||||
| France | ||||
| Abstract: http://www.sciencedirect.com/science/article/pii/S0398762013011383 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | French | Methodology, Retrospective database analysis | |
| Mortality after hemorrhagic stroke: data from general practice (The Health Improvement Network). | ||||
| González-Pérez A, Gaist D, Wallander MA, McFeat G & García-Rodríguez LA | ||||
| Spanish Centre for Pharmacoepidemiological Research (CEIFE) | ||||
| Neurology. 2013 Aug 6;81(6):559-65. doi: 10.1212/WNL.0b013e31829e6eff. Epub 2013 Jul 10. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23843467 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Hematology | 2013 | English | Retrospective database analysis | |
| Rapid identification and recruitment of patients from The Health Improvement Network (THIN) primary care patient data for a health-related quality of life (HRQoL) study of patients with atrial fibrillation (AF) in the UK. | ||||
| Vial D, Thompson M, Cockbain C, Hogan S, Johnson M & Bourke A | ||||
| Cegedim | ||||
| 18th Annual International Meeting (ISPOR)
New Orleans, USA 2013 Value in Health 16(3):A45-6 |
||||
| Article, Poster | ||||
| UK | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)00327-6/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2013 | English | Retrospective database analysis | |
| Reclassification of European patients' cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm. | ||||
| Halcox JP1, Tubach F2, Sazova O3, Sweet S4, Medina J5; EURIKA steering committee. | ||||
| 1Wales Heart Research Institute, Cardiff University School of Medicine, UK halcoxjp@cardiff.ac.uk. 2Assistance-Publique-Hôpitaux de Paris, France; Université Paris Diderot, France. 3AstraZeneca Global Medical Affairs, UK. 4Research Evaluation Unit, Oxford PharmaGenesis Ltd, UK. 5Observational Research Centre, AstraZeneca, Spain. | ||||
| Eur J Prev Cardiol. 2015 Feb;22(2):200-2. doi: 10.1177/2047487313507680. Epub 2013 Oct | ||||
| Article | ||||
| Europe | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24092875 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Prospective study | |
| Signal Refinement of Drug-Induced Thrombocytopenia using The Health Information Network (THIN) Database. | ||||
| Liu K, Hauben M & Bate A | ||||
| Pfizer | ||||
| 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Montreal, Canada | ||||
| Poster | ||||
| UK | ||||
| Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Hematology | 2013 | English | Retrospective database analysis | |
| The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom: Is Current Practice Consistent with the 2012 ESC Recommendations. | ||||
| COTTÉ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M | ||||
| (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
| 16th Annual European ISPOR Congress Dublin, Ireland | ||||
| Poster | ||||
| France, Germany, Italy, Spain, UK | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03127-6/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: risk of coronary events and peptic ulcer bleeding. | ||||
| Garcia R LA, Johansson S & Cea S L | ||||
| Spanish Centre for Pharmacoepidemiological Research (CEIFE) | ||||
| Thromb Haemost. 2013 Nov;110(5):1014-24. doi: 10.1160/TH13-03-0225. Epub 2013 Jul 25. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23884111 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| REAL-WORLD CHARACTERIZATION OF HYPERTENSION PATIENTS IN JAPAN: A 1-YEAR OVERVIEW | ||||
| Crawford B1, Ong SH, Falvey H. | ||||
| 1Adelphi Values, Tokyo, Japan | ||||
| Asian J Pharmaceutical and Clinical Research 2013; 6 (suppl 4): 93-96. | ||||
| Article | ||||
| Japan | ||||
| Abstract: http://innovareacademics.in/journals/index.php/ajpcr/article/view/364 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: a network meta-analysis with the adjustment for the possible bias from open label studies. | ||||
| Morimoto T1, Crawford B2, Wada K2, Ueda S3. | ||||
| 1Division of General Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan. 2Adelphi Values, Tokyo, Japan. 3Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus School of Medicine, Okinawa, Japan | ||||
| European Heart Journal
http://dx.doi.org/10.1093/eurheartj/eht307.P531First published online: 1 August 2013 Poster at European Society of Cardiology (August 30 – September 4, 2013, Amsterdam, Netherlands) |
||||
| Article, Poster | ||||
| Japan | ||||
| Abstract: http://eurheartj.oxfordjournals.org/content/34/suppl_1/P531 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Meta analysis | |
| Impact of Partner Bereavement on Quality of Cardiovascular Disease Management | ||||
| Shah SM, Carey IM, Harris T & et al | ||||
| St. George's University of London Division of Population Health Sciences and Education | ||||
| Circulation. 2013; 128: 2745-2753 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://circ.ahajournals.org/content/128/25/2745.long | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| Observational study of ezetimibe discontinuation in primary care practices in the UK | ||||
| Hall GC, Amber V, O'Regan C & Jameson K | ||||
| Grimsdyke House Ravenscroft Park, LondonUK | ||||
| Curr Med Res Opin. 2013 Dec;29(12):1737-45. doi: 10.1185/03007995.2013.842164. Epub 2013 Sep 23. | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24032417 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | Retrospective database analysis | |
| Rapid identification and recruitment of patients from the health improvement network (thin) primary care patient data for a health-related quality of life (HRQOL) study of patients with atrial fibrillation (AF) in the United Kingdom. | ||||
| Vial D, Thompson M, Cockbain C, Hogan S, Johnson M & Bourke A | ||||
| Cegedim | ||||
| Value in Health, 16(3):A45-6 | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)00327-6/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2013 | English | Retrospective database analysis | |
| Comparaison des ventes de médicaments antihypertenseurs dans cinq pays européens en 2009 | ||||
| Thao Khamsing W1, Juillard-Condat B2 | ||||
| 1 Direction de la recherche, des études, de l’évaluation et des statistiques (Drees), 2UMR 1027 (INSERM, université Toulouse III). | ||||
| Revue française des affaires sociales, 2013/3 n° 3, p. 88-107 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | French | ||
| Adherence to the JNC 7 Treatment Guidelines and Impact on Patient Outcomes | ||||
| Rowan Christopher G, Shah Ankit J and Spaeder Jeffrey A | ||||
| 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, August, 2013 | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2013 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany | ||||
| Breitscheidel L1, Ehlken B1, Kostev K1, Oberdiek MS2, Sandberg A2, Schmieder RE3 | ||||
| 1 IMS Health GmbH & Co, Munich, Germany 2 Daiichi Sankyo, Munich, Germany, 3 University Hospital Erlangen | ||||
| Journal of Medical Economics 2011, EPub Nov 8 Journal of Medical Economics 2012, Vol 15(1): 155-165 |
||||
| Article | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective | ||||
| McDonald H1, Diamantopoulos A2, Wells P3, Lees M4, Folkerts K5, Forster F6, Ananthapavan J6 | ||||
| 1 Bayer Inc., Toronto, Canada 2 Symmetron Limited, London, UK 3 Department of Medicine, Ottawa Hospital and University of Ottawa, Canada 4 Bayer plc, Uxbridge, UK 5 Bayer Pharma AG, Wuppertal, Germany 6 IMS Health, London, UK | ||||
| Journal of Medical Economics Vol. 15, No. 5, 2012, 1–12 | ||||
| Article | ||||
| Canada | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22494267 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Cost effectiveness | |
| Assessing the cost-effectiveness of the recommended antihypertensive drug classes in France using a lifetime Markov model. | ||||
| Gerlier L1, Midy F2, Lièvre M3, Maurel F4, Cohn E2, Vellopoulou K1, Lamotte M1 | ||||
| 1 IMS HEOR, Vilvoorde, Belgium 2 Haute Autorité de Santé, Saint-Denis La Plaine, France 3 Université Claude Bernard, Lyon, France 4 IMS HEOR, Puteaux, France | ||||
| Poster | ||||
| France | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Cost effectiveness | |
| Cost-effectiveness of ticagrelor in the management of acute coronary syndromes in Belgium. | ||||
| Chevalier P1, Lamotte M1, Petit C2 | ||||
| 1 IMS HEOR, Vilvoorde, Belgium 2 Astra Zeneca Belgium, Brussels, Belgium | ||||
| 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany | ||||
| Abstract, Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Cost effectiveness | |
| A health economic evaluation of Omega-3 ethyl esters 0 in the secondary prevention post- MI. | ||||
| Gerlier L1, Vellopoulou K1, Lamotte M1, Lacey L2, Einroos A3, Carr E4 | ||||
| 1 IMS Health, Vilvoorde, Belgium 2 Lacey Solutions Ltd, Skerries, Ireland 3 Abbott Laboratories, Tallinn, Estonia 4 Abbott Laboratories, Allschwil, Switzerland | ||||
| 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany | ||||
| Abstract, Poster | ||||
| Estonia, Ireland | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Cost effectiveness | |
| The cost of diabetes complications in Belgium. | ||||
| Lamotte M1, Chevalier P1 | ||||
| 1 IMS Health, Vilvoorde, Belgium | ||||
| 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany | ||||
| Abstract, Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2012 | English | Cost consequence, Cost of illness | |
| Economic evaluation of Rivaroxaban in stroke prevention among patients with Atrial Fibrillation in Greece | ||||
| Kourlaba G1, Maniadakis N1, Andrikopoulos G2, Vardas P3, Llyod A4, Asukai Y4, Evers T5 | ||||
| 1National School of Public Health, Athens, Greece, 2Henry Dunant Hospital, Athens, Greece, 3University of Crete, Heraklion, Crete , Greece, 4IMS Health, London, UK, 5Bayer Schering Pharma AG, Wuppertal, Germany | ||||
| ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany | ||||
| Poster | ||||
| Greece | ||||
| Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Economic evaluation | |
| Cost-effectiveness of Rivaroxaban for the prevention of stroke and systemic embolism in adult patients with Non-Valvular Atrial Fibrillation with one or more risk factors – a UK perspective | ||||
| Asukai Y1, Duran A1, Lloyd A1, McLeod EJ1, Evers T2, Broughton J3 | ||||
| 1IMS Health, London, UK, 2Bayer HealthCare AG, Wuppertal, Germany, 3Bayer Plc, Newbury, UK | ||||
| ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany | ||||
| Poster | ||||
| UK | ||||
| Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Cost effectiveness | |
| Economic evaluation of Rivaroxaban in the treatment of Deep Vein Thrombosis in Greece | ||||
| Kourlaba G1, Maniadakis N1, Giannoukas A2, Katsamouris A3, Katsenis K4, Lazarides M5, Matsagas M6, Lowin J7, McLeod EJ8, Bamber L9 | ||||
| 1National School of Public Health, Athens, Greece, 2University of Thessaly, Larissa, Greece, 3University of Crete, Heraklion, Crete, Greece, 4University of Athens, Athens, Greece, 5Democritus University, Thrace, Greece, 6University of Ioannina, Ioannina, Greece, 7IMS Health, London , UK, 8IMS Health, London, UK, 9Bayer Pharma AG, Wuppertal, Germany | ||||
| ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany | ||||
| Poster | ||||
| Greece | ||||
| Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Economic evaluation | |
| Cost-effectiveness of Rivaroxaban versus Acenocumarol in the stroke prevention in patients with Non-Valvular Atrial Fibrilation in the Spanish setting | ||||
| Restovic G1, Carcedo D1, McLeod EJ2, Guillermin ALG3, Evers T4 | ||||
| 1Bayer Pharma, Barcelona-Spain, Barcelona, Barcelona, Spain, 2IMS Health, London, UK, 3IMS Health, London , UK, 4Bayer Schering Pharma AG, Wuppertal, Germany | ||||
| ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany | ||||
| Poster | ||||
| Spain | ||||
| Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Cost effectiveness | |
| Prevention of stroke in patients with Atrial Fibrillation: Cost-Utility Analysis of Rivaroxaban versus Warfarin in Slovakia | ||||
| Psenkova M1, Lukac M2, Mackovicova S3, Stachova M2, Bielik J4, Pietsch GA5, Asukai Y6, Lloyd A6, Evers T7 | ||||
| 1Pharm-In, Bratislava, Slovak Republic, 2Bayer, Bratislava, Slovak Republic, 3Pharm-In, spol. s r.o., Bratislava, Slovak Republic, 4Trencin University, Trencin, Slovak Republic, 5Bayer Schering Pharma AG, Wupertal, GA, Germany, 6IMS Health, London, UK, 7Bayer Schering Pharma AG, Wuppertal, Germany | ||||
| ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany | ||||
| Poster | ||||
| Slovakia | ||||
| Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Cost utility | |
| The impact of Atrial Fibrilation symptoms in the health related quality of life in Spanish population (Ulises Study) | ||||
| Arribas F1, Montull E2, LLobet X2, Perulero N3, Badia X4 | ||||
| 1Hospital Universitario 12 de Octubre, MADRID, Spain, 2SANOFI AVENTIS S.A., BARCELONA, Spain, 3IMS Health, S.A., Barcelona, Spain, 4IMS Health, Barcelona, Spain | ||||
| ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany | ||||
| Poster | ||||
| Spain | ||||
| Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Quality of life | |
| Guidelines for primary cardiovascular prevention are not being observed in clinical practice. EURIKA study shows European shortcomings. | ||||
| Perk J1. | ||||
| 1Institutionen för hälso- och vårdvetenskap, Linnéuniversitetet, Kalmar | ||||
| Lakartidningen. 2012 Jun 5-19;109(23-24):1164-6. | ||||
| Article | ||||
| Europe | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22834209 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Prospective study | |
| A Cross-Sectional Assessment of Atrial Fibrillation Management Among French Patients in Primary Care. | ||||
| SABOURET P., WILLEMS C., COTTE FE., MARIE MERCIER F., BLIN P | ||||
| 15th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Berlin, Germany | ||||
| Poster | ||||
| France | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)02673-3/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain. | ||||
| Huguet M, Shakespeare A, Haug HM, Miadi-Fargier H, Restovic G, Rafols C, Kempf C | ||||
| ISPOR Annual European Congress, Berlin, Germany | ||||
| Poster | ||||
| France, Spain | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)02765-9/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Pricing & Reimbursement | |
| Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study. | ||||
| Schmieder RE1, Goebel M, Bramlage P. | ||||
| 1Nephrology and Hypertension, University Hospital Erlangen, Germany | ||||
| Vasc Health Risk Manag. 2012;8:177-86. doi: 10.2147/VHRM.S29915. Epub 2012 Mar 15 | ||||
| Article | ||||
| Germany | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22536072 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Prospective study | |
| Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. | ||||
| Horsfall LJ, Nazareth I & Petersen I | ||||
| UCL Research Department of Primary Care and Population Health | ||||
| Circulation. 2012 Nov 27;126(22):2556-64. doi: 10.1161/CIRCULATIONAHA.112.114066. Epub 2012 Oct 30. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23110860 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Clinical Attributes, Treatment, and Control In Hypertension (CATCH) Study - France | ||||
| David W, David D, Vasalisa S | ||||
| ESH Annual Meeting London. 2012. | ||||
| Poster | ||||
| France | ||||
| Abstract: http://www.tuttocongressi.it/website/congresses/CongressDetail2.aspx?idc=1966&cont=110&in=W | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Clinical Attributes, Treatment, and Control In Hypertension (CATCH) Study - Italy | ||||
| David W1, David D, Vasalisa S | ||||
| 1Merck &Co., Inc., Kenilworth, NJ, USA | ||||
| ESH Annual Meeting London. 2012. | ||||
| Poster | ||||
| France, Italy | ||||
| Abstract: http://www.tuttocongressi.it/website/congresses/CongressDetail2.aspx?idc=1966&cont=110&in=W | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective cohort analysis, Retrospective database analysis | |
| Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis. | ||||
| Piccinocchi G1, Laringe M, Guillaro B, Arpino G, Piccinocchi R, Nigro G, Calabro P. | ||||
| 1Co.Me.Gen. Coop (Cooperativa Medicina Generale Napoli), Cooperative of Primary Care Physicians, Via Cintia Parco S. Paolo 45, 80126, Naples | ||||
| Clin Drug Investig. 2012 Nov;32(11):771-7. doi: 10.1007/s40261-012-0005-5. | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23018284 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Management of cardiovascular risk factors for primary prevention: evaluation of Turkey results of the EURIKA study. | ||||
| Abaci A1. | ||||
| 1Department of Cardiology, Medicine Faculty of Gazi University, Ankara, Turkey | ||||
| Turk Kardiyol Dern Ars. 2012 Mar;40(2):135-42. doi: 10.5543/tkda.2012.01827. | ||||
| Article | ||||
| Turkey | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22710584 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Prospective study | |
| Optimizing adherence in hypertension: a comparison of outcomes and costs using single tablet regimens vs individual component regimens. | ||||
| Belsey JD | ||||
| JB Medical Ltd | ||||
| J Med Econ. 2012;15(5):897-905. doi: 10.3111/13696998.2012.689792. Epub 2012 May 24. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22548677 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2 | ||||
| Collins GS & Altman DG | ||||
| Wolfson College Annexe Centre for Statistics in Medicine | ||||
| 21;344:e4181
BMJ2012; 344 doi: http://dx.doi.org/10.1136/bmj.e4181(Published 21 June 2012) |
||||
| Article | ||||
| UK | ||||
| Abstract: http://www.bmj.com/content/344/bmj.e4181 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK. | ||||
| Collins GS & Altman DG. | ||||
| Wolfson College Annexe Centre for Statistics in Medicine | ||||
| Heart. 2012 Jul;98(14):1091-7. doi: 10.1136/heartjnl-2012-302014. Epub 2012 Jun 11. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22689714 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Prescribing of nicotine replacement therapy to cardiovascular disease patients in England | ||||
| Langley TE, Szatkowski L, McNeill A, Coleman T & Lewis S. | ||||
| University of Nottingham UK Centre for Tobacco Control Studies | ||||
| Addiction Volume 107, Issue 7, pages 1341–1348, July 2012 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2012.03794.x/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Socio-demographic variation in chest pain incidence and subsequent coronary heart disease in primary care in the United Kingdom. | ||||
| Walters K, Rait G, Hardoon S, Kalaitzaki E, Petersen I & Nazareth I. | ||||
| UCL Department of Primary Care and Population Health | ||||
| Eur J Prev Cardiol. 2014 May;21(5):566-75. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22617118 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Prospective study, Retrospective database analysis | |
| Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. | ||||
| Dallongeville J1, Banegas JR, Tubach F, Guallar E, Borghi C, De Backer G, Halcox JP, Massó-González EL, Perk J, Sazova O, Steg PG, Artalejo FR; EURIKA Investigators | ||||
| 1Service d'Epidemiologie et Santé Publique, Institut Pasteur de Lille, INSERM U744, Univ Lille Nord de France | ||||
| Eur J Prev Cardiol. 2012 Jun;19(3):541-50. doi: 10.1177/1741826711407705. Epub 2011 Apr 18. | ||||
| Article | ||||
| Europe | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21502280 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Prospective study | |
| The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. | ||||
| Dubreuil M, Rho Y H, Man A, Zhu Y, Zhang, Love T, Ogdie A, Gelfand J M & Choi H K | ||||
| Boston University School of Medicine Section of Rheumatology | ||||
| Ann Rheum Dis. 2013 Jul;72(7):1188-93. doi: 10.1136/annrheumdis-2012-202007. Epub 2012 Aug 17. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22904260 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Dermatology | 2012 | English | Retrospective database analysis | |
| Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network. | ||||
| Loftus J, Christopoulou D, Blak BT, Hards M. | ||||
| Eur J Ophthalmol. 2012 May-Jun;22(3):376-87. doi: 10.5301/ejo.5000068. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22034021 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Ophthalmology | 2012 | English | ||
| Use of antidepressant serotoninergic medications and cardiac valvulopathy: a nested case-control study in the health improvement network (THIN) database. | ||||
| Lapi F, Nicotra F, Scotti L, Vannacci A, Thompson M, Pieri F, Mugelli N, Zambon A, Corrao G, Mugelli A & Rubino A | ||||
| Cegedim | ||||
| Br J Clin Pharmacol. 2012 Sep;74(3):536-44. doi: 10.1111/j.1365-2125.2012.04224.x. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22356433 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Neurological disorders | 2012 | English | Retrospective database analysis | |
| Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study. | ||||
| Cazzola M1, Calzetta L, Bettoncelli G, Cricelli C, Romeo F, Matera MG, Rogliani P. | ||||
| 1Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy | ||||
| Respir Med. 2012 Feb;106(2):249-56. doi: 10.1016/j.rmed.2011.07.021 | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21856140 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Respiratory disease | 2012 | English | Retrospective database analysis | |
| Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study. | ||||
| Trifirò G1, Mokhles MM, Dieleman JP, van Soest EM, Verhamme K, Mazzaglia G, Herings R, de Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, van Camp G, Zanettini R & Sturkenboom MC. | ||||
| 1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands. g.trifiro@erasmusmc.nl | ||||
| Drug Saf. 2012 Feb 1;35(2):159-71. doi: 10.2165/11594940-000000000-00000. | ||||
| Article | ||||
| Europe, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22204718 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Drug safety, Neurological disorders | 2012 | English | Retrospective database analysis | |
| The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease. | ||||
| Mokhles MM1, Trifirò G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM, Mazzaglia G, Herings R, Luise Cd, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, Camp Gv, Zanettini R, Sturkenboom MC | ||||
| 1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands. | ||||
| Pharmacol Res. 2012 Mar;65(3):358-64. doi: 10.1016/j.phrs.2011.11.009. Epub 2011 Nov 23. | ||||
| Article | ||||
| Italy, Netherlands, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22123498 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Drug safety, Neurological disorders | 2012 | English | Retrospective database analysis | |
| Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing’s syndrome: cohort study. | ||||
| Fardet L, Petersen I & Nazareth I. | ||||
| UCL MRC General Practice Research Framework | ||||
| BMJ2012; 345 doi: http://dx.doi.org/10.1136/bmj.e4928(Published 30 July 2012) BMJ: 345:e4928 |
||||
| Article | ||||
| UK | ||||
| Abstract: http://www.bmj.com/content/345/bmj.e4928 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Endocrinology | 2012 | English | Retrospective database analysis | |
| REAL-WORLD CHARACTERIZATION OF HYPERTENSION PATIENTS IN JAPAN: A 1-YEAR OVERVIEW. | ||||
| Crawford B, Ong SH, Falvey H. | ||||
| ISPOR (September 2 – 4, 2012, Taipei, Taiwan). | ||||
| Poster | ||||
| Japan | ||||
| Abstract: http://www.ispor.org/E6E2C004-9FF1-4F7E-897E-BC292C74DF07/FinalDownload/DownloadId-F47364CB0E2D4F7A2A77F55DA0BDB30E/E6E2C004-9FF1-4F7E-897E-BC292C74DF07/conferences/Taipei0912/documents/ISPOR_5th-AP-Final-Program_Website.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Real World Evidence | |
| Real World Patient Profile of Patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 Regions of China. | ||||
| Li XY, Crawford B, Liao YH, Tanaka E, Wang D, Sung J, Zheng J, McDonald J. | ||||
| ISPOR (June 2 – 6, 2012, Washington DC | ||||
| Poster | ||||
| China | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)00765-6/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | ||
| Observational cohort study of the safety of digoxin use in women with heart failure | ||||
| Flory JH, Ky B, Haynes K, M Brunelli S, Munson J, Rowan C, Strom BL & Hennessy S | ||||
| Division of Endocrinology, Diabetes, and Metabolism in the Department of Medicine at New York-Presbyterian Hospital/Weill Cornell Medical Center | ||||
| 13;2(2):e000888
BMJ Open2012;2:e000888 doi:10.1136/bmjopen-2012-000888 |
||||
| Article | ||||
| UK | ||||
| Abstract: http://bmjopen.bmj.com/content/2/2/e000888.full | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study | ||||
| Forde KA, Haynes K, Troxel AB, Trooskin S, Osterman MT, Kimmel SE, Lewis JD & Lo Re V 3rd | ||||
| University of Pennsylvania Perelman School of Medicine | ||||
| J Viral Hepat. 2012 Apr;19(4):271-7. doi: 10.1111/j.1365-2893.2011.01545.x. Epub 2011 Nov 13. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636529/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Infectious disease | 2012 | English | Retrospective database analysis | |
| Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study | ||||
| Trifirò G1, Mokhles MM, Dieleman JP, van Soest EM, Verhamme K, Mazzaglia G, Herings R, de Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, van Camp G, Zanettini R, Sturkenboom MC. | ||||
| 1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands | ||||
| Drug Saf. 2012 Feb 1;35(2):159-71. doi: 10.2165/11594940-000000000-00000. | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22204718 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Neurological disorders | 2012 | English | Retrospective database analysis | |
| External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data. | ||||
| Corrao G1, Nicotra F1, Parodi A1, Zambon A1, Soranna D1, Heiman F2, Merlino L3, Mancia G4. | ||||
| 1 Unit of Biostatistics and Epidemiology, Department of Statistics, University of Milano-Bicocca, Italy 2 Cegedim Strategic Data, BKL Consulting s.r.l., MIlan, Italy 3 Operative Unit of Territorial Health Services, Region Lombardia,Milan, Italy, 4 Department of Clinical and Preventive Medicine, University of Milano-Bicocca, Italy. | ||||
| J Clin Epidemiol. 65(11):1190-9. | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=external+adjustment+for+unmeasured+confounders+improved+drug-outcome+association+estimates+based+on+health+care+utilization+data | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network. | ||||
| Rowan CG, Brunelli SM, Munson J, Flory J, Reese PP, Hennessy S, Lewis J, Mines D, Barrett JS, Bilker W & Strom BL. | ||||
| University of Pennsylvania School of Medicine | ||||
| Pharmacoepidemiol Drug Saf. 2012 May;21(5):494-506. doi: 10.1002/pds.3199. Epub 2012 Mar 16. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22422642 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2012 | English | Retrospective database analysis | |
| Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. | ||||
| Lo Re V 3rd, Haynes K, Ming EE, Wood Ives J, Horne LN, Fortier K, Carbonari DM, Hennessy S, Cardillo S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Roy J, Freeman CP, Razzaghi H, Holick CN, Esposito DB, Van Staa TP, Bhullar H & Strom BL. | ||||
| Cegedim | ||||
| Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1202-15. doi: 10.1002/pds.3318. Epub 2012 Jul 5. | ||||
| Article | ||||
| UK, USA | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22763953 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2012 | English | Retrospective database analysis | |
| GLP-1 Receptor Agonist (GLP1ra) and Insulin Efficacy in Primary Health Care | ||||
| Hall GC, McMahon AD, Dain M-P & et al | ||||
| Sanofi | ||||
| Diabetes 61(S1):A276 | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2012 | English | Retrospective database analysis | |
| "Calcium Channel Blockers, Losartan, and the Risk of Incident Gout among Patients with Hypertension: A Population-Based Case-Control Study" | ||||
| Choi HK, Soriano LC, Zhang Y & Rodríguez LA | ||||
| Boston University | ||||
| British Medical Journal (BMJ) 344:d8190. doi: 10.1136/bmj.d8190 | ||||
| Article | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort. | ||||
| Poli A1, Tragni E, Casula M, Filippi A, Diotti R, Brignoli O, Cricelli C, Catapano AL; CHECK Group. | ||||
| 1Epidemiology and Preventive Pharmacology Centre, SEFAP, Department of Pharmacological Sciences, University of Milan | ||||
| Nutr Metab Cardiovasc Dis. 2012 Apr;22(4):327-36 | ||||
| Abstract | ||||
| Italy | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2012 | English | Retrospective database analysis | |
| Enhanced persistence in hypertensive patients treated with angiotensin receptor blockers in the UK. | ||||
| Breitscheidel L1,Sandberg A2, Kostev K3, Holz B3, Oberdiek A4 | ||||
| 1 IMS Health GmbH & Co, Munich, Germany 3 IMS Health GmbH & Co, Munich, Germany 4 Daiichi Sankyo, Munich, Germany | ||||
| The ESH 21st European Meeting on Hypertension, Milan, Italy. 2011. | ||||
| Poster | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| The patterns of treatment persistence with antihypertensive medications in France. | ||||
| Breitscheidel L1, Sandberg A2, Kostev K1, Holz B1, Oberdiek A2 | ||||
| 1 IMS Health GmbH & Co, Munich, Germany 2 Daiichi Sankyo, Munich, Germany | ||||
| The ESH 21st European Meeting on Hypertension, Milan, Italy. 2011. | ||||
| Poster | ||||
| France | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| Treatment patterns and medication costs in hypertensive patients treated with combinations of angiotensin receptor blockers, amlodipine and hydrochlorothiazide in Germany. | ||||
| Breitscheidel L1,Sandberg A2, Kostev K1, Holz B1, Oberdiek A2. | ||||
| 1 IMS Health GmbH & Co, Munich, Germany 2 Daiichi Sankyo, Munich, Germany | ||||
| The IHEA 8th World Congress, Toronto, Canada. 2011. | ||||
| Oral presentation | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| Persistence and compliance in hypertensive patients treated with fixed or unfixed combinations of Angiotensin Receptor Blockers, Amplodipine and Hydrochlorothiazide. | ||||
| Sandberg A1, Kostev K2, Ehlken B3, Holz B2, Oberdiek A1 | ||||
| 1Daiichi Sankyo Europe GmbH, Munich, Germany, 2IMS Health GmbH & Co., Frankfurt, Germany, 3IMS Health GmbH & Co., Munich, Germany | ||||
| ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA | ||||
| Poster | ||||
| Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Compliance | |
| Persistence and compliance in Hypertension treatment with Olmesartan Medoxomil – analysis of real-life prescription data | ||||
| Sandberg A1, Kostev K2, Ehlken B3, Holz B2, Oberdiek A1 | ||||
| 1Daiichi Sankyo Europe GmbH, Munich, Germany, 2IMS Health GmbH & Co., Frankfurt, Germany, 3IMS Health GmbH & Co., Munich, Germany | ||||
| ISPOR 16th Annual International Meeting, May 21-25 2011, Baltimore, USA | ||||
| Poster | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Compliance | |
| Bluthochdrucksenkende Therapie mit freien und fixen Kombinationen aus Sartanen plus Amplodipin oder Hydrochlorothiazid - Behandlungsmuster und Persistenz bei Patienten mit Diabetes mellitus Typ 2 | ||||
| Ehlken B1, Kostev K1, Holz B1, Oberdiek A2 | ||||
| 1 IMS Health GmbH & Co. OHG. Frankfurt / München, 2 Daiichi Sankyo Europe GmbH | ||||
| DDG, Germany, 2. Juni 2011 | ||||
| Poster | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | German | ||
| Real world add-on and switch patterns for platelet and aggregation inhibitors | ||||
| Löfroth E, Bruce S, Myrén KJ. | ||||
| IMS Consulting Group, Stockholm, Sweden. | ||||
| ISPOR 14th Annual European Congress, 2010, 5-8 November, Madrid, Spain | ||||
| Poster | ||||
| Sweden | ||||
| Abstract: http://www.ispor.org/congresses/Spain1111/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Clinical practice, Vascular disease | 2011 | English | Epidemiological study, Retrospective database analysis | |
| Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer’s perspective | ||||
| Duran A1, Sengupta N2, Diamantopoulos A3, Forster F1, Kwong4, Lees M5 | ||||
| 1 IMS Health, London, UK 2 Worldwide Market Access, Janssen Global Services, Raritan, NJ, USA 3 Symmetron Ltd, London, UK 4 Harbor-UCLA Medical Center and UCLA David Geffen School of Medicine, Los Angeles, CA, USA 5 Bayer HealthCare, Uxbridge, UK | ||||
| Journal of Medical Economics Vol. 14, No. 6, 2011, 824–834 | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Cost effectiveness | |
| Determining initial and follow-up costs of cardiovascular events in a US managed care population. | ||||
| Chapman RH, Liu LZ, Girase PG, Straka RJ. | ||||
| IMS Health, Pfizer Inc. | ||||
| BMC Cardiovascular Disorders 2011; 11:11ff. | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Cost analysis | |
| Clinical and patient-reported outcomes of triple combination of Olmesartan Medoxomil (Om ), Amlodipine Besylate (Aml) And Hydrochlorothiazide (Hct) in hypertensive patients | ||||
| Ehlken B1, Claus V1, Shlaen R1, Oberdiek AMS2 | ||||
| 1 IMS Health, Munich, Germany, 2 Daiichi Sankyo Europe, Munich, Germany | ||||
| ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain | ||||
| Poster | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Survey research | |
| Persistence in Hypertension treatment with Olmesartan Medoxomil versus Valsartan - Analysis of real-life prescription data in Germany | ||||
| Ehlken B1, Kostev K2, Breitscheidel L1, Sandberg A3, Holz B2, Oberdiek AM3 | ||||
| 1IMS Health, Munich, Germany, 2IMS Health, Frankfurt, Germany, 3Daiichi Sankyo Europe, Munich, Germany | ||||
| ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain | ||||
| Poster | ||||
| Germany | ||||
| Abstract: http://www.ispor.org/congresses/Spain1111/Posters2.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Cost analysis | |
| Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer's Perspective | ||||
| Duran A1, Sengupta N2, Diamantopoulos A3, Forster F1, Kwong L4, Lees M5. | ||||
| 1 IMS Health, London, UK 2 Janssen Global Services, Raritan, NJ, USA 3 Symmetron Ltd, London, UK 4 Harbor-UCLA Medical Center and UCLA David Geffen School of Medicine, Los Angeles, CA, USA 5 Bayer HealthCare, Uxbridge, UK | ||||
| Pharmacoeconomics. 2011 Dec 21. p87 | ||||
| Article | ||||
| USA | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22187932 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Cost effectiveness | |
| Use of Hospital Claims Data to Estimate the Clinical and Economic Burden of Acute Coronary Syndrome Rehospitalizations in Real-World Clinical Practice | ||||
| Hess G1, Bhandary D2, Gandhi S2, Kumar D1, Fonseca E1, Gold A2 | ||||
| 1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA | ||||
| Circulation: Cardiovascular Quality and Outcomes, Fall 2011 | ||||
| Abstract | ||||
| USA | ||||
| Abstract: http://circoutcomes.ahajournals.org/cgi/content/short/4/6_MeetingAbstracts2011/AP11?rss=1 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| Adherence To Medications With Once-A-Day (Qd) And Twice-A-Day (Bid) Dosing Formulations In Acute Coronary Syndrome (Acs) Patients | ||||
| Hess G1, Bhandary D2, Fonseca E1, Kumar D1, Potter D2, Smith D2, Gandhi SK2 | ||||
| 1IMS Health (formally SDI),Plymouth Meeting, PA, USA, 2AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA | ||||
| Value in health 14 ( 2011 ) a1 – a214 | ||||
| Article | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(11)00390-1/fulltext | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Burden of illness, Quality of life | |
| Adherence to Medications with Once-a-Day (QD) and Twice-a-Day (BID) Dosing Formulations in Acute Coronary Syndrome patients | ||||
| Hess G1, Bhandary D2, Fonseca E1, Kumar D1, Potter D2, Smith D2, Gandhi SK2 | ||||
| 1 IMS Health, Plymouth Meeting, USA 2 AstraZeneca Pharmaceuticals LP, Wilmington, USA | ||||
| Poster presented at ISPOR 16th Annual International Meeting. Baltimore, MD, May 21-25, 2011 | ||||
| Poster | ||||
| USA | ||||
| Abstract: http://www.ispor.org/meetings/baltimore0511/Posters1.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Real World Evidence | |
| Health-care costs of losartan and candesartan in the primary treatment of hypertension | ||||
| Henriksson M, Russell D, Bodegard J, Kjeldsen S, Hasvold P, Stålhammar J, Levin LÅ. | ||||
| IMS Health, Stockholm. (Formally Pygargus) | ||||
| J Hum Hypertens. 2011 Feb;25(2):130-6. doi: 10.1038/jhh.2010.36. Epub 2010 Apr 8. | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20376078 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Cost analysis | |
| Healthcare encounters among heart failure patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden | ||||
| Wikstrom G1, Stalhammar J2, Ariely R3, Linder R4, Ogbonnaya A5, Stern L5 | ||||
| 1Uppsala University, Department of Medical Sciences, Cardiology, Uppsala, Sweden, 2Uppsala University, Department of Public Health and Caring Sciences, Uppsala,Sweden, 3 Novartis Pharmaceuticals Corporation, East Hanover, USA, 4IMS Health (Formally Pygargus AB), Stockholm, Sweden, 5Analytica International, New York, USA | ||||
| European Heart Failure Congress, Gothenbourg, May 21-24, 2011 | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://spo.escardio.org/SessionDetails.aspx?eevtid=46&sessId=7804&subSessId=1013&searchQuery=&presId=54107&doc=Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Cost utility, Retrospective database analysis | |
| Mortality and admission rates among heart failure patients with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden | ||||
| Wikstrom G1, Stalhammar J2, Ariely R3, Linder R4, Ogbonnaya A5, Stern L5 | ||||
| 1Uppsala University, Department of Medical Sciences, Cardiology, Uppsala, Sweden, 2Uppsala University, Department of Public Health and Caring Sciences, Uppsala,Sweden, 3Novartis Pharmaceuticals Corporation,East Hanover,USA, 4IMS Health,(Formally Pygargus AB)Stockholm, Sweden, 5Analytica International, New York, USA | ||||
| European Heart Failure Congress, Gothenbourg, May 21-24, 2011 | ||||
| Abstract | ||||
| Sweden | ||||
| Abstract: http://spo.escardio.org/Abstract.aspx?eevtid=46&fp=P1289 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective cohort analysis, Retrospective database analysis | |
| Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. | ||||
| Jose´ R. Banegas 1,2*, Esther Lo´pez-Garcı´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7, Julian P. Halcox8, Claudio Borghi 9, Elvira L. Masso´-Gonza´lez 10, Francisco J. Jime´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando Rodrı´guez-Artalejo1,2 | ||||
| 1 Department of Preventive Medicine and Public Health, School of Medicine, Universidad Auto´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2 CIBER of Epidemiology and Public Health, Madrid, Spain; 3 Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 5 Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6 Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7 Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8 Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN, UK; 9 Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca Farmace´utica Spain, S.A., 28003 Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publique–Hoˆpitaux de Paris and Universite´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium | ||||
| Eur Heart J. 2011 Sep;32(17):2143-52 | ||||
| Article | ||||
| Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21471134 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Observational study, Prospective study | |
| Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. | ||||
| García R LA, Cea S L, Martín M E & Johansson S | ||||
| Spanish Centre for Pharmacoepidemiologic Research | ||||
| BMJ2011; 343 doi: http://dx.doi.org/10.1136/bmj.d4094(Published 19 July 2011) | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.bmj.com/content/343/bmj.d4094 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. | ||||
| Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP, Borghi C, Massó-González EL, Tafalla M, Perk J, De Backer G, Steg PG, Rodríguez-Artalejo F. | ||||
| BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704. | ||||
| Article | ||||
| Austria, Belgium, France, Germany, Greece, Norway, Russian Federation, Spain, Sweden, Switzerland, Turkey, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21923932 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Observational study, Prospective study | |
| Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice. | ||||
| De la Iglesia B, Potter JF, Poulter NR, Robins MM, Skinner J. | ||||
| University of East Anglia School of Computing Sciences | ||||
| 97(6):491-9
Heart doi:10.1136/hrt.2010.203364 |
||||
| Article | ||||
| UK | ||||
| Abstract: http://heart.bmj.com/content/early/2010/11/20/hrt.2010.203364 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| Risk of falls associated with antihypertensive medication: self-controlled case series. | ||||
| Meeraus W, Petersen I & Gilbert R | ||||
| University of Nottingham Division of Epidemiology and Public Health | ||||
| Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):879-84. doi: 10.1002/pds.2176. Epub 2011 Jul 11. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21744415 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: a longitudinal population-based study. | ||||
| Hardoon SL, Whincup PH, Petersen I, Capewell S, Morris RW. | ||||
| J Epidemiol Community Health. 2011 Sep;65(9):770-4. doi: 10.1136/jech.2009.098087. Epub 2010 Jun 1 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20515898 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | ||
| Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study | ||||
| Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F & Soumerai SB | ||||
| Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston | ||||
| BMJ 2011;342:d108 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.bmj.com/content/342/bmj.d108 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice. | ||||
| Corrao G1, Nicotra F1, Parodi A1, Zambon A1, Heiman F2, Merlino L3, Fortiono I3, Cesana G4, Mancia G4. | ||||
| 1 Department of Statistics, Unit of Biostatistics and Epidemiology, University of Milano-Bicocca, 2 Cegedim Strategic Data, Milan, Italy, 3 Operative Unit of Territorial Health Services, Lombardy Region, Milan, Italy 4 Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Italy. | ||||
| Hypertension. 58(4):566-72. | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Cardiovascular+Protection+by+Initial+and+Subsequent+Combination+of+Antihypertensive+Drugs+in+Daily+Life+Practice. | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | Retrospective database analysis | |
| A cohort study to measure the impact of statin therapy on short-term mortality following a pneumonia episode. | ||||
| Douglas I, Evans S & Smeeth L | ||||
| LSTHM | ||||
| SAPC Annual Scientific Meeting, Bristol. 2011. | ||||
| Poster | ||||
| UK | ||||
| Abstract: https://sapc.conference-services.net/programme.asp?conferenceID=2491&action=prog_titles | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Infectious disease, Respiratory disease | 2011 | English | Retrospective database analysis | |
| Effect of statin treatment on short term mortality after pneumonia episode: cohort study. | ||||
| Douglas I, Evans S & Smeeth L | ||||
| Faculty of Epidemiology and Population Health | ||||
| BMJ2011; 342 doi: http://dx.doi.org/10.1136/bmj.d1642(Published 06 April 2011) | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.bmj.com/content/342/bmj.d1642 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Respiratory disease | 2011 | English | Retrospective database analysis | |
| A national survey on aspirin patterns of use and persistence in community outpatients in Italy. | ||||
| Filippi A1, Bianchi C, Parazzini F, Cricelli C, Sessa E, Mazzaglia G. | ||||
| 1Italian College of General Practitioners, Florence, Italy. | ||||
| Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):695-703 | ||||
| Abstract | ||||
| Italy | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2011 | English | Retrospective Field Study | |
| CKD awareness and blood pressure control in the primary care hypertensive population. | ||||
| Ravera M1, Noberasco G, Weiss U, Re M, Gallina AM, Filippi A, Cannavò R, Ravera G, Cricelli C, Deferrari G. | ||||
| 1Department of Internal Medicine, University of Genoa, Department of Cardio-Nephrology, Azienda Ospedaliera Universitaria San Martino, Italy | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Nephrology | 2011 | English | Retrospective database analysis | |
| Patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from IMPROVE-HF Trial) | ||||
| O’Connor CM, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, Reynolds D, Walsh MN, Yancy CW, Fonarow GC | ||||
| Am J Cardiol 2011; 107:205-258 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Validity of claims-based definitions of impaired left ventricular systolic function in Medicare patients | ||||
| Li Q, Glynn RJ, Dreyer NA, Liu J, Mogun H, Setoguchi S | ||||
| Pharmacoepidemiol Drug Saf 2011; 20(7); 700-708 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Challenges in comparing effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors for hypertension in Medicare data | ||||
| Setoguchi S, Shrank WH, Liu J, Lee JC, Saya U, Winkelmayer WC, Dreyer NA | ||||
| Clinical Pharmacology & Therapeutics 2011; 89(5):674-82 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2011 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Association of HbA1c with the risk of cardiovascular events in patients with type 2 diabetes: a cohort study of 40, 204 patients in primary care. | ||||
| Östgren C1, Sundstrom C2, Svennblad B3, Lohm L4, Nilsson P5, Johansson G2 | ||||
| 1 Linköping University, Linköping, Sweden 2 Uppsala University, Uppsala, Sweden 3 Uppsala Clinical Research Center, Uppsala, Sweden 4 AstraZeneca Nordic, Södertälje, Sweden 5 Malmö University Hospital, Malmö, Sweden | ||||
| European Association for Study of Diabetes, Annual Meeting 2011, Lisbon, Portugal | ||||
| Oral presentation | ||||
| Sweden | ||||
| Abstract: http://www.easdvirtualmeeting.org/resources/association-of-hba1c-with-the-risk-of-cardiovascular-events-in-patients-with-type-2-diabetes-a-cohort-study-of-40-204-patients-in-primary-care | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2011 | English | Real World Evidence | |
| Validation of the AF-QOL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. | ||||
| Arribas F1, Ormaetxe JM2, Peinado R3, Perulero N4, Ramírez P5, Badia X4 | ||||
| 1Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, Spain 2Unidad de Arritmias. Servicio de Cardiología, Hospital de Basurto. Bilbao, Spain 3Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain 4Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 5MEDA Pharma; Madrid, Spain | ||||
| Europace. 2010;12(3):364-70. | ||||
| Article, Manuscript in preparation | ||||
| Spain | ||||
| Abstract: http://europace.oxfordjournals.org/cgi/content/abstract/eup421 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Observational study, Prospective study, Quality of life | |
| The cost and effectiveness of adherence-improving interventions for lipid-lowering and antihypertensive drugs. | ||||
| Chapman RH1, Ferrufino CP1, Kowal S1, Classi P2, Roberts CS2. | ||||
| 1 IMS Health, Falls Church, VA 22046, US 2 Pfizer Inc, New York, NY, USA | ||||
| Int J Clin Pract. 2010 Jan;64(2):169-81. | ||||
| Article | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20089007 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Cost effectiveness | |
| Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in managed care enrollees? | ||||
| Hussein MA, Chapman RH, Benner JS, Tang SSK, Solomon HA, Joyce A, Foody JM | ||||
| American Journal of Cardiovascular Drugs 2010; 10(3):193-202 | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Compliance, Retrospective cohort analysis | |
| Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees. | ||||
| Chapman RH, Yeaw J, Roberts CS | ||||
| BMC Cardiovascular Disorders 2010; 10:29ff | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective cohort analysis | |
| An epidemiological evaluation of the impact of percutaneous coronary interventions on the length of stay and mortality of patients hospitalized with acute coronary syndromes | ||||
| Chevalier P, Lamotte M | ||||
| IMS Health Consulting, Brussels, Belgium | ||||
| ISPOR 13th Annual European Congress, 2010, November 6-9, Prague, Czech Republic | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | ||
| The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications. | ||||
| Chapman RH,1 Kowal SL,1 Cherry SB,1 Ferrufino CP,1 Roberts CS,2 Chen L.2 | ||||
| 1. IMS Health, 2. Pfizer Inc. | ||||
| Value in Health 2010; 13(6):685-694. | ||||
| Article | ||||
| USA | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00774.x/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Cost effectiveness | |
| A Large Observational Study of Cardiovascular Outcomes Associated With Atorvastatin or Simvastatin Therapy in Hypertensive Patients Without Prior Cardiovascular Disease. | ||||
| Foody JM, Joyce AT, Jeffers BW, Liu LZ, Benner JS. | ||||
| 1Division of Cardiovascular Medicine, Department of Internal Medicine, Harvard Medical School, Boston, MA; 2PharMetrics, Watertown, MA; 3Global Health Economics & Outcomes Research, Pfizer, New York, NY; 4Weill Medical College of Cornell University, New York, NY; 5IMS, Falls Church, VA; and 6University of Pennsylvania School of Medicine, Philadelphia, PA. | ||||
| Am J Ther. 2010 Mar 8. [Epub ahead of print] | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Genotyping in patients in treatment with acenocumarol cost-effectiveness | ||||
| Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3 | ||||
| Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 2 Servicio de Hemoterapia y Hemostasia, Hospital Clinic Barcelona, 3 Progenika Biopharma S.A. | ||||
| Revista Española de Economia de la Salud; 8(2): 77-84 | ||||
| Article | ||||
| Spain | ||||
| Abstract: http://www.economiadelasalud.com/ediciones/82/08_pdf/acenocumarol.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | Spanish | ||
| Differences in quality of life according to the type of atrial fibrillation [Spanish]. | ||||
| Peinado R1, Arribas F2, Ormaetxe JM3, Badia X4. | ||||
| 1 Hospital Universitario La Paz, Madrid, Spain 2 Hospital Universitario 12 de Octubre, Madrid, Spain 3 Hospital Universitario de Basurto, Bilbao, Vizcaya, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
| Revista Esp. Cardiol. 2010; 63: 1402-1409 | ||||
| Article | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | Spanish | Quality of life | |
| Switching From Atorvastatin to Simvastatin in Patients at High Cardiovascular Risk: Effects on Low-Density Lipoprotein Cholesterol | ||||
| Aronow HD, Hess G, Hill J, Kuznik A, Liu LZ. | ||||
| Am J Ther. 2010 Mar-Apr;17(2):167-75 | ||||
| Article | ||||
| USA | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19770794 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Burden of illness, Epidemiological study, Prospective study, Quality of life | |
| Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension | ||||
| Kjeldsen SE, Stålhammar J, Hasvold P, Bodegard J, Olsson U, Russell D. | ||||
| IMS Health, Stockholm. (Formally Pygargus) | ||||
| J Hum Hypertens. 2010 Apr;24(4):263-73. doi: 10.1038/jhh.2009.77. Epub 2009 Nov 5. | ||||
| Article | ||||
| Sweden | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19890371 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Observational study | |
| A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care. | ||||
| Mazzaglia G, Filippi A, Alacqua M, Cowell W, Shakespeare A, Mantovani LG, Bianchi C, Cricelli C. | ||||
| Thromb Haemost. 2010 May;103(5):968-75. doi: 10.1160/TH09-08-0525. Epub 2010 Mar 9. | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20216987 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | ||
| An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. | ||||
| Collins GS & Altman DG | ||||
| Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford | ||||
| BMJ. 2010 May 13;340:c2442. doi: 10.1136/bmj.c2442. | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20466793 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes | ||||
| Gunathilake W, Song S, Sridharan S, Fernando DJ & Idris I | ||||
| Sherwood Forest Hospitals Foundation Trust, Nottinghamshire | ||||
| QJM. 2010 Nov;103(11):881-4. doi: 10.1093/qjmed/hcq135. Epub 2010 Jul 30 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://qjmed.oxfordjournals.org/content/103/11/881.long | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2010 | English | Retrospective database analysis | |
| Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database. | ||||
| Yuan Z, Weinstein R, Zhang J, Cheng M, Griffin G, Zolynas R, Plotnikov AN, Lee MS, Oppenheimer L & Burton P | ||||
| Pharmaceutical Research and Development, Johnson and Johnson, Raritan | ||||
| Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):911-20. doi: 10.1002/pds.1987. | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20602345 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Prescription trends for dopamine agonists in UK primary care - The influence of safety alerts concerning valvular heart disease | ||||
| Schade R, Dieleman JP & Sturkenboom MC | ||||
| IMS Health | ||||
| Pharmacoepidemiol Drug Saf. 2010 Aug;19:S1-S347 | ||||
| Abstract | ||||
| UK | ||||
| Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf? | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2010 | English | Retrospective database analysis | |
| Risk of Myocardial Infarction in UK Primary Care Patients with Hepatitis C Virus Infection | ||||
| Kimberly Forde K, Kevin Haynes K, James Lewis J & LoRe V | ||||
| Healthcore Inc | ||||
| 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management | ||||
| Poster | ||||
| UK | ||||
| Abstract: https://vivo.upenn.edu/vivo/display/citfd287960 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Immunology and Vaccination, Infectious disease | 2010 | English | Retrospective database analysis | |
| SSRI and Risk of Congenital Cardiac Abnormalities | ||||
| Petersen I, Gilbert R, Evans S, Marston L & Nazareth I | ||||
| University College London | ||||
| ICPE 2010 Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
| Abstract, Poster | ||||
| UK | ||||
| Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/19 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Risk of falls associated with antihypertensive medication: population-based case-control study | ||||
| Gribbin J, Hubbard R, Gladman JR, Smith C, Lewis S. | ||||
| Division of Epidemiology and Public Health, University of Nottingham | ||||
| Age Ageing. 2010 Sep;39(5):592-7. doi: 10.1093/ageing/afq092. Epub 2010 Jul 21 | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20650874 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2010 | English | Retrospective database analysis | |
| An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study | ||||
| Collins GS & Altman DG | ||||
| BMJ 2010;340:c2442 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.bmj.com/content/340/bmj.c2442 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | ||
| Increased risk of Myocardial Infarction and Stroke following Exacerbation of Chronic Obstructive Pulmonary Disease | ||||
| Donaldson GC, Hurst JR, Smith CJ, Hubbard RB & Wedzicha JA | ||||
| Chest. 2010 May;137(5):1091-7. doi: 10.1378/chest.09-2029. Epub 2009 Dec 18. | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20022970 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Respiratory disease | 2010 | English | ||
| Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. | ||||
| Corrago G1, Parodi A1, Zambon A1, Heiman F2, Filippi A3, Cricelli C 3,4,Merlino L5, Mancia G6. | ||||
| 1 Department of Statistics, Unit of Biostatistics and Epidemiology, University of Milano-Bicocca, 2 BKL Consulting s.r.l., Milan, 3 Italian College of General Practitioners, 4 Health Search, Florence, 5 Operative Unit of Territorial Health Services, Region Lombardia, 6 Department of Clinical and Preventive Medicine, University of Milano-Bicocca, Milan, Italy | ||||
| Journal of Hypertension 2010, 28:1584–1590. | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Reduced+discontinuation+of+antihypertensive+treatment+by+two-drug+combination+as+first+step.+Evidence+from+daily+life+practice. | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: a longitudinal population-based study. | ||||
| Hardoon SL, Whincup PH, Petersen I, Capewell S & Morris RW | ||||
| Department of Primary Careand Population Health, University College London | ||||
| Journal of Epidemiology & Community Health 65(9):770-4 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20515898 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Use of serotoninergic medications and cardiac valvulopathy: A nested case-control study in the Health Improvement Network (THIN) Database. | ||||
| Rubino A, Lapi F, Nicotra F, Zambon A, Scotti L, Thompson M, Vannacci A, Corrao G & Mugelli A | ||||
| Cegedim | ||||
| Pharmacoepidemiology and Drug Safety (19): S1-S347 | ||||
| Abstract | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice | ||||
| Iglesia B, Potter J, Poulter N, Robins M & Skinner J | ||||
| School of Computing Sciences, University of East Anglia | ||||
| Heart BMJ doi:10.1136/hrt.2010.203364 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://heart.bmj.com/content/early/2010/11/20/hrt.2010.203364 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Incidence of Diabetic Retinopathy and Diabetic Macular Edema in Newly Diagnosed Type 1 and Type 2 Diabetic Patients | ||||
| Martin-Merino E, Fortuny J, Plana E, Rivero E & Garcia-Rodriguez L | ||||
| CEIFE | ||||
| Pharmacoepidemiology and Drug Safety (19): S1-S347 | ||||
| Abstract | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | Retrospective database analysis | |
| Incidence of Diabetic Retinopathy and Diabetic Macular Edema in Newly Diagnosed Type 1 and Type 2 Diabetic Patients | ||||
| Martin-Merino E, Fortuny J, Plana E, Rivero E & Garcia-Rodriguez L | ||||
| CEIFE | ||||
| ICPE 2010 Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
| Abstract, Poster | ||||
| UK | ||||
| Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/19 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2010 | English | Retrospective database analysis | |
| Incidence rates of retinal artery thrombosis in solid tumor cancer patients in the THIN Database | ||||
| Gastanaga V, Wentworth C, Hughes G, Xue F, Ganesh V, Verma M, Dimery I & Zhao S | ||||
| Amgen | ||||
| Pharmacoepidemiol Drug Saf. 2010 Aug;19:S1-S347. | ||||
| Abstract, Poster | ||||
| UK | ||||
| Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf? | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Oncology, Ophthalmology | 2010 | English | Retrospective database analysis | |
| Incidence rates of edema in solid tumor cancer patients in the THIN Database. | ||||
| Gastanaga V, Wenstowrth C, Ganesh V, Hughes G, Xue F, Verma M, Dimery I & Zhao S | ||||
| Amgen | ||||
| Pharmacoepidemiol Drug Saf. 2010 Aug;19:S1-S347 | ||||
| Abstract, Poster | ||||
| UK | ||||
| Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf? | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Oncology | 2010 | English | Retrospective database analysis | |
| The registry to evaluate anticoagulation in atrial fibrillation (REAL-AF) | ||||
| Matchar D, Garcia D, Samsa G, Sander S, VanderMaelen CP, Su Z, Ezekowitz M | ||||
| AHA Scientific Sessions, Chicago, IL, Nov. 2010 | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE-HF | ||||
| Walsh MN, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Inge PJ, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Fonarow GC | ||||
| J Cardiac Fail 2010; 16:940-949 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the registry to improve the use of evidence-based heart failure therapies in the outpatient setting (IMPROVE-HF) | ||||
| Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, O’Connor CM, Reynolds D, Walsh MN, Yancy CW | ||||
| Circulation 2010; 122:585-596. | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF | ||||
| Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade, M, Heywood JT, McBride M, Mehra MR, O’Connor CM, Reynolds D, Walsh MN | ||||
| Am J Cardiol 2010; 105(12):1773-1779 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Electronic health records and quality of care for heart failure | ||||
| Walsh MN, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Fonarow GC | ||||
| Am Heart J 2010; 159(4):635-642 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Influence of renal function on the use of guideline-recommended therapies for patients with heart failure | ||||
| Heywood TJ, Fonarow GC, Yancy CW, Albert NM, Curtis, AB, Stough WG, Gheorghiade M, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN | ||||
| Am J Cardiol 2010; 105(8):1140-1146 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: Findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) | ||||
| Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O’Connor CM, Reynolds D, Walsh MN | ||||
| Am Heart J 2010; 159(2):238-244 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: Findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) | ||||
| Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O’Connor CM, Reynolds D, Walsh MN | ||||
| Am Heart J 2010; 159(2):238-244 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: Findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) | ||||
| Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O’Connor CM, Reynolds D, Walsh MN | ||||
| Am Heart J 2010; 159(2):238-244 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Interim Results of the Registry to Evaluate Anticoagulation in Atrial Fibrillation (REAL-AF) | ||||
| Matchar, DB, Ezekowitz M, Garcia DA, Samsa GP, Sander S, Zhaohui S, VaderMaelen C | ||||
| American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease, May 2010. | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2010 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Incidence and temporal pattern of hospital readmissions for atrial fibrillation in managed care patients following prior hospitalization for this condition | ||||
| Kim M, Lin J1, Hussein M2, Battleman D2 | ||||
| 1 Sanofi-Aventis, Bridgewater, NJ, US 2 IMS Health, Falls Church, VA, US | ||||
| Current Medical Research Opinion. 2009; In press | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Abstract: http://informahealthcare.com/doi/abs/10.1185/03007990902869235 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Burden of illness | |
| Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation | ||||
| Kim M1, Klingman D2, Lin J3, Pathak P2, Battleman D2 | ||||
| 1 Northwestern University, Chicago, IL, USA 2 IMS Health, Falls Church, VA, US 3 Sanofi-aventis, Bridgewater, NJ, US | ||||
| Ann Pharmacother. 2009 May;43(5):840-8. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19417111?ordinalpos=&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.SmartSearch&log$=citationsensor | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| Cost-Effectiveness Of Rivaroxaban Versus Enoxaparin For Prophylaxis After Total Hip Or Total Knee Replacement In Korea | ||||
| Kim J1, Pollock R2, Jung S3, Diamantopoulos A4, Lees M5 | ||||
| 1IMS Health, Seoul, South Korea, 2IMS Health, Basel, Switzerland, 3Bayer Korea, Seoul, South Korea, 4IMS Health, London, UK, 5Bayer HealthCare, Uxbridge, UK | ||||
| ISPOR 14th Annual International Meeting, Orlando, Florida, USA May 16-20, 2009 | ||||
| Poster | ||||
| Korea | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| The cost-effectiveness of titration to goal with branded rosuvastatin compared to generic simvastatin in patients with elevated low-density lipoprotein cholesterol: primary and secondary prevention in the Belgian health care setting. | ||||
| Van den Steen D1, Petit C2, Lamotte M1 | ||||
| 1 IMS Health Consulting, Brussels, Belgium, 2 AstraZeneca, Brussels, Belgium | ||||
| ISPOR 12th Annual European Congress, 2009, October 24-27, Paris, France | ||||
| Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| Are high-risk hypertensive patients prescribed concomitant statin therapy? A retrospective cohort study. | ||||
| Chapman RH1, Petrilla AA1, Berman L, Benner J2, Tang SS | ||||
| 1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US | ||||
| American Journal of Cardiovascular Drugs 2009; 9(5):299-308 | ||||
| Article | ||||
| USA | ||||
| Abstract: http://www.ingentaconnect.com/content/adis/acv/2009/00000009/00000005/art00003 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. | ||||
| Benner JS1, Chapman RH2, Petrilla AA2, Tang SSK, Rosenberg N, Schwartz JS | ||||
| 1 Formerly of IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US | ||||
| American Journal of Hralth-System Pharmacy 2009; 66(16):1471-1477 | ||||
| Article | ||||
| USA | ||||
| Abstract: http://archinte.ama-assn.org/cgi/content/abstract/165/10/1147 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| A Review Of Treatment Patterns Of Patients With Pulmonary Arterial Hypertension In Three European Countries | ||||
| Angalakuditi M1, Wright D2, Gaskin M2, Fakhoury W2 | ||||
| 1Eli Lilly and Company, Indianapolis, IN, USA, 2IMS Health, London, UK | ||||
| ISPOR 14th Annual International Meeting, Orlando, Florida, USA 16 - 20 May 2009 | ||||
| Poster | ||||
| France, Germany, UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Review | |
| Comparing the cost of treatment for peripheral artery disease and coronary artery disease in US managed care enrollees. | ||||
| Jaff MR1, Chapman RH2, Ferrufino C2, Kowal S2, Smith D, Girase P, Rosen E3, Engelhart L3. | ||||
| 1 Massuchesetts General Hospital, Boston, MA, USA 2 IMS Health, Falls Church, VA, USA 3 Cordis, Warren, NJ, USA | ||||
| American College of Cardiology 58th Annual Scientific Session, 2009, March 29-31, Orlando, FL, USA | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| A life-long cost-effectiveness Markov model comparing high-dose versus standard statin therapy in Acute Coronary Syndrome patients | ||||
| C. Plesnila-Frank1, Y. Asukai2, B. Ehlken1, E. Giannitsis3, J. Rieber4, K. Berger1, J. Mardekian5, D. Rublee5 | ||||
| 1 Health Economics and Outcomes Research, IMS Health, Munich, Germany; 2 Health Economics and Outcomes Research, IMS Health, London, England; 3 Medizinische Klinik III, University Hospital Heidelberg, Heidelberg, Germany; 4 Medizinische Poliklinik der Universität München, University Hospital Munich, Munich, Germany; 5 Pfizer Inc. (Statistics and Global Outcomes Research), NYC, New York, US | ||||
| Abstract for ISPOR in Orlando, Florida, US, May 16th-20th 2009 | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| Economic evaluation of inhaled Iloprost in primary pulmonary hypertension in the UK | ||||
| Ashley D1, Lloyd AC2, Gilmour L1 | ||||
| 1Bayer Healthcare Pharmaceuticals Inc, Newbury, UK, 2IMS Health, London, UK | ||||
| ISPOR 12th Annual European Congress, Paris France, 24-27 October 2009 | ||||
| Poster | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Economic evaluation | |
| A health-economic evaluation of highly concentrated and purified omega-3 polyunsaturated fatty acids (N-3 Pufas) in the secondary prevention after myocardial infarction (MI) in Romania. | ||||
| Vinereanu D1, Cinteză M1, Tele P2, Gerlier L3, Lamotte M3 | ||||
| 1 Carol Davila University Emergency Hospital, Bucharest, Romania 2 Carol Davila University of Medicine and Pharmacy Bucharest, Romania 3 IMS Health, Brussels, Belgium | ||||
| 48th Romanian National Cardiology Congress, 2009, September 19-22, Sinaia, Romania | ||||
| Poster | ||||
| Romania | ||||
| Abstract: http://ideas.repec.org/a/wkh/phecon/v24y2006i8p783-795.html | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| Impact of intervention type on antihypertensive medication adherence effects. | ||||
| Schabert VF1, Dupclay L2, Roy S1, Burudpakdee C1, Goldberg EL1 | ||||
| 1 IMS Health, Inc., Falls Church, VA, USA 2 Novartis, East Hanover, NJ, USA | ||||
| Academy of Health 2009 Annual research Meeting, 2009, June 29, Chicago, IL, USA | ||||
| Poster | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Review | |
| Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. | ||||
| Robert J Straka1, Larry Z Liu2, Prafulla S Girase3, Allyson DeLorenzo4 and Richard H Chapman5 | ||||
| 1 University of Minnesota College of Pharmacy, Minneapolis, MN, USA, 2 Pfizer Inc, New York, NY, USA, 3 IMS Health, Watertown, MA, USA, 4 Columbia University, New York, NY, USA and 5 IMS Health, Falls Church, VA, USA | ||||
| Cardiovascular Diabetology 2009; 8:53-63 | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2009 | English | Cost analysis, Retrospective cohort analysis | |
| Can adherence to antihypertensive therapy be used to promote adherence to statin therapy? | ||||
| Chapman RH1, Pelletier EM1, Smith PJ1, Roberts CS2 | ||||
| 1 IMS Health, Inc., Falls Church, VA, USA 2 Pfizer Inc., New York, NY, USA | ||||
| Patient Preference and Adherence, 2009, 3:265-275 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. | ||||
| Benner, JS1, Chapman RH2, Petrilla AA2, Tang SSK3, Rosenberg N4, Schwartz JS5 | ||||
| 1 The Brookings Institution, Washington, DC, USA 2 IMS Health, Inc., Falls Church, VA, USA 3 Pfizer Inc., New York, NY, USA 4 Sanofi-Aventis, Bridgewater, NJ, USA 5 University of Pennsylvania, Philadelphia, PA, USA | ||||
| American Journal of Health-System Pharmacy, 2009, 66(16): 1471-1477 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| Generic and therapeutic statin switches and disruptions in therapy. | ||||
| Chapman RH1, Benner JS2, Girase P1, Benigno M3, Axelsen K3, Liu LZ3, Nichol MB4 | ||||
| 1 IMS Health, Inc., Falls Church, VA, USA 2 The Brookings Institution, Washington, DC, USA, 3 Pfizer Inc., New York, NY, USA 4 University of Southern California, Los Angeles, CA, USA | ||||
| Current Medical Research and Opinion, 2009, 25(5): 1247-1260 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| Comparing the cost of treatment for peripheralartery disease and coronary artery disease in US managed care enrollees. | ||||
| Jaff MR, Chapman RH1, Ferrufino CP1, Kowal S1, Smith D, Girase P1, Rosen E, Engelhart L | ||||
| 1 IMS Health, Inc., Falls Church, VA, USA | ||||
| American College of Cardiology 58th Annual Scientific Session, 2009, March 29-31, Orlando, FL, USA | ||||
| Oral presentation | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| Does better adherence to antihypertensive and statin medication lead to fewer cardiovascular events in United States managed care enrollees? | ||||
| Chapman RH1, Yeaw JM1, Roberts CS2 | ||||
| 1 IMS Health, Inc., Falls Church, VA, USA 2 Pfizer Inc., New York, NY, USA | ||||
| American Society of Hypertension 24th Annual Scientific Meeting & Exposition, 2009, May 6-9, San Francisco, CA | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| Cost-effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering medications. | ||||
| Chapman RH1, Kowal S1, Cherry SB, Ferrufino CP1, Roberts CS2, Chen L2 | ||||
| 1 IMS Health, Inc., Falls Church, VA, USA 2 Pfizer inc., New York, NY, USA | ||||
| Journal of General Internal Medicine, 2009, 24(S1): S49 | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| Therapy interruptions in patients switched from branded to other generic statins. | ||||
| Chapman RH1, Benner JS2, Girase P1, Benigno M3, Axelsen K3, Liu LZ3, Nichol MB4 | ||||
| 1 IMS Health, Inc., Falls Church, VA, USA 2 The Brookings Institution, Washington, DC, USA 3 Pfizer Inc., New York, NY, USA 4 Univeristy of Southern California, Los Angeles, CA, USA | ||||
| Value in Health, 2009, 12(3) A161. ISPOR 13th Annual International Meeting, 2009, May 16-20, Orlando, FL, USA | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| Does the impact of atrial fibrillation on HRQOL differ among types of atrial fibrillation? | ||||
| Arribas F1, Ormaetxe JM2, Peinado R3, Fernández C4, Ramírez P4, Badia X5. | ||||
| 1Hospital 12 de Octubre, Madrid, Spain. 2Hospital de Basurto, Bilbao, Spain. 3Hospital La Paz, Madrid, Spain 4Meda Pharma, Madrid, Spain. 5IMS Health, Barcelona, Spain. | ||||
| ISPOR 12th Annual European Congress 2009, 24 to 27 October, Paris, France | ||||
| Oral presentation | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Quality of life | |
| Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain | ||||
| Wild D1, Murray M2, Donatti2, | ||||
| 1 Oxford Outcomes Ltd, Oxford, UK 2 Health Protection Agency, London, UK 3 IMS Health, London, UK | ||||
| Expert Review of Pharamacoeconomics and Outcomes Research October 2009, Vol. 9, No. 5, Pages 467-474 | ||||
| Article | ||||
| Spain, UK, USA | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Wild+D%5Bfirst+author%5D+AND+vitamin&TransSchema=title | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Observational study | |
| Can adherence to antihypertensive therapy be used to promote adherence to statin therapy? | ||||
| Chapman RC1, Pelletier EM2, Smith PJ2, Roberts CS3 | ||||
| 1IMS Health, Falls Church, VA, USA, 2IMS Health, Watertown, MA, USA, 3Pfizer Inc., New York NY, USA | ||||
| Patient Preference and Adherence, 2009, 3: 265-275 | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Compliance | |
| Patterns and predictors of discontinuation of rhythm-control drug therapy in patients with newly diagnosed atrial fibrillation. | ||||
| Kim MH, Klingman D, Lin J, Battleman DS. | ||||
| Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. Michael.Kim@nmff.org | ||||
| Pharmacotherapy. 2009 Dec;29(12):1417-26. | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective database analysis | |
| Rates of venous thromboembolism occurrence in medical patients among the insured population. | ||||
| Spyropoulos AC, Hussein M, Lin J, Battleman D. | ||||
| McMaster University, Hamilton General Hospital, Hamilton, ON L8L 2X2, Canada. spyropa@mcmaster.ca | ||||
| Thromb Haemost. 2009 Nov;102(5):951-7. | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective database analysis | |
| Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study. | ||||
| Spyropoulos AC, Hussein M, Lin J, Battleman D. | ||||
| University of New Mexico Health Sciences Center, Albuquerque, NM, USA. aspyropoulos2787@msn.com | ||||
| J Thromb Thrombolysis. 2009 Nov;28(4):458-64. | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective database analysis | |
| Im langzeitvergleich sind sartane die bessere Alternative [In a long-run comparison sartanes are the better alternative] | ||||
| Sonntag F1, Kotowa W2 | ||||
| 1 Niedergelassener Kardiologe, Henstedt-Ulzburg, Germany 2 IMS Health Economics & Outcomes Research, Nuremberg, Germany | ||||
| Cardio News, 2009, 12(4): p.47 | ||||
| Newspaper article | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | German | Economic evaluation | |
| Kosteneffektivität von Sartanen im Vergleich zu anderen Antihypertensiva bei Hypertonikern [Cost-efficacy of sartans in comparison to other Antihypertensives in patients with hypertension] | ||||
| Sonntag F1, Brüggenjürgen B2, Kotowa W3, Mathes J3, Haß B3 | ||||
| 1 Niedergelassener Kardiologe, Henstedt-Ulzburg 2 Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Universitätsmedizin Charité, Berlin 3 IMS Health Economics & Outcomes Research, Nürnberg" | ||||
| Medreview Nr. 7, 10. Jahrgang, Mai 2009 (75. Jahrestagung der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. 16. bis 18. April 2009 in Mannheim) | ||||
| Article | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | German | Cost effectiveness | |
| Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total knee replacement in the UK and Spain | ||||
| Brosa M1, Diamantopoulos A2, Forster F2, Duran A2, Lees M3, Gilmour L4, Ashley D4, Piñol C5 | ||||
| 1Oblikue Consulting, Barcelona, Spain 2 IMS Health, London, UK 3 Bayer HealthCare, Uxbridge, UK 4 Bayer plc, Newbury, UK 5 Bayer SA, Barcelona, Spain | ||||
| 14th Congress of the European Association of Hospital Pharmacists, Barcelona, Spain, 25-27 March 2009 | ||||
| Poster | ||||
| Spain, UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| Cost-effectiveness of Rivaroxaban for prevention of venous thromboembolism (VTE) after total hip or knee replacement (THR, TKR) in the USA | ||||
| Kwong L1, Duran A2, Diamantopoulos A2, Sengupta N3, Lees M4. | ||||
| 1Dept of Orthopaedic Surgery, Harbor-UCLA Medical Center, Torrance, USA 2IMS Health, London, UK 3 Johnson & Johnson, California, USA 4Bayer HealthCare, London, UK | ||||
| Journal of Thrombosis and Haemotosis, Volume 7 Supplement 2, July 2009, Abstracts from the XXII ISTH Congress | ||||
| Poster | ||||
| USA | ||||
| Abstract: http://www.blackwellpublishing.com/isth2009/abstract.asp?id=78214 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| Cost-effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement or total knee replacement in Colombia | ||||
| Pereira R1, Duran A2, Lindner L3, Toro W4, Arango CH5 | ||||
| 1IMS Health, Lisbon, Portugal, 2IMS Health, London, United Kingdom, 3IMS Health, Barcelona, Spain, 4Bayer Schering Pharma, Bogotá, Colombia, 5Synergia Consultoría y Gestión S.A, Bogotá D.C, Colombia | ||||
| ISPOR 2nd Latin America Conference (10-12 September 2009), Rio de Janeiro, Brazil | ||||
| Abstract | ||||
| Colombia | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Cost effectiveness | |
| Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. | ||||
| Benner JS1, Chapman RH1, Petrilla AA1, Tang SSK2, Rosenberg N2, Schwartz JS. | ||||
| 1 IMS Health, Falls Church, VA, USA 2 Pfizer Inc., New York, NY, USA 3 University of Pennsylvania, Philadelphia USA | ||||
| Am J Health Syst Pharm. 2009 Aug 15;66(16):1471-7 | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Burden of illness | |
| Effects of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy After Hospital Discharge on Subsequent Rehospitalization for Acute Myocardial Infarction and Heart Failure | ||||
| Hess G1,2, Preblick R3, Hill J1, Plauschinat C1, Yaskin J4 | ||||
| 1IMS Health, Former SDI, Plymouth Meeting, PA, USA, 2Leonard Davis Institute for Health Economics and Policy, University of Pennsylvania, Philadelphia, PA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Department of Health Policy, Jefferson Medical College, Philadelphia, PA | ||||
| Congest Heart Fail. 2009 Jul-Aug;15(4):170-5 | ||||
| Article | ||||
| USA | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19627290 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Respiratory disease | 2009 | English | Burden of illness, Quality of life | |
| Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. | ||||
| Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. | ||||
| Circulation. 2009 Oct 20;120(16):1598-605. doi: 10.1161/CIRCULATIONAHA.108.830299. Epub 2009 Oct 5. | ||||
| Article | ||||
| Italy | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19805653 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | ||
| An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. | ||||
| Collins GS & Altman DG | ||||
| Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford | ||||
| BMJ 2009;339:b2584 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.bmj.com/content/339/bmj.b2584 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective database analysis | |
| Statins in heart failure: retrospective cohort study using routine primary care data | ||||
| Ryan R P, McManus R J, Mant J, Macleod J A & Hobbs R | ||||
| Primary Care Clinical Sciences, Primary Care Clinical Sciences Building, University of Birmingham | ||||
| Ann Med. 2009;41(7):490-6. doi: 10.1080/07853890903022819. | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19521887 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Gastrointestinal disorders | 2009 | English | Retrospective database analysis | |
| Longitudinal assessment of lipid abnormalities in a sample of Italian patients: prevalence and attainment of goal/normal levels | ||||
| Ambegaonkar B 1, Heiman F 2, Soro M 3, Sazonov V. 1 | ||||
| 1Merck & Co., Inc, Whitehouse Station, NJ, USA, 2Cegedim Strategic Data, Milan, Italy, 3MSD Italy, Rome, Italy | ||||
| ISPOR Annual European Meeting, Paris. 2009 | ||||
| Poster | ||||
| Italy | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective cohort analysis | |
| Increased risk of Myocardial Infarction and Stroke following Exacerbation of Chronic Obstructive Pulmonary Disease | ||||
| Donaldson GC, Hurst JR, Smith CJ, Hubbard RB & Wedzicha JA | ||||
| Academic Unit of Respiratory Medicine, Royal Free and University College Medical School, University College London | ||||
| Chest 137(5):1091-7 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20022970 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective database analysis | |
| Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials | ||||
| Smeeth L, Douglas I, Hall A J, Hubbard R & Evans S | ||||
| Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine | ||||
| British Journal of Clinical Pharmacology 67(1):99-109 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Effect+of+statins+on+a+wide+range+of+health+outcomes%3A+a+cohort+study+validated+by+comparison+with+randomized+trials | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | Retrospective database analysis | |
| Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. | ||||
| Smeeth L, Douglas I, Hall A J, Hubbard R & Evans S | ||||
| Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine | ||||
| Br J Clin Pharmacol. 2009 Jan;67(1):99-109. doi: 10.1111/j.1365-2125.2008.03308.x. Epub 2008 Nov 5. | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19006546 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Vascular disease | 2009 | English | Retrospective database analysis | |
| The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes | ||||
| Wang TY, Fonarow GC, Hernandez AF, Liang L, Ellrodt G, Nallamothu BK, Shah BR, Cannon CP, Peterson ED | ||||
| Archives of Internal Medicine 2009; 169(15):1411-1419 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Cardiac resynchronization therapy utilization for heart failure: Findings from IMPROVE HF | ||||
| Curtis AB, Yancy CW, Albert NM, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN, Fonarow GC | ||||
| Am Heart J 2009; 158(6):956-967 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrilliators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF | ||||
| Mehra, MR, Yancy CW, Albert NM, Curtis AB, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML, O’Connor CM, Reynolds D, Walsh MN, Fonarow GC | ||||
| Heart Rhythm. 2009; 6:1727-1734 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrilliators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF | ||||
| Mehra, MR, Yancy CW, Albert NM, Curtis AB, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML, O’Connor CM, Reynolds D, Walsh MN, Fonarow GC | ||||
| Heart Rhythm. 2009; 6:1727-1734 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Influence of patient age and sex on delivery of guideline recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF | ||||
| Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, Mehra M, O'Connor CM, Reynolds D, Walsh MN | ||||
| Am Heart J 2009; 157:754-762.e2 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Performance feedback a common thread in the process to provide optimal heart failure care | ||||
| Howlett JG | ||||
| JACC. 2009; 53(5):423-425 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure data From the GWTG-HF (Get With The Guidelines-Heart Failure) registry | ||||
| Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED | ||||
| JACC 2009; 53(5):416-422 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF | ||||
| Mehra, MR, Yancy CW, Albert NM, Curtis AB, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML, O’Connor CM, Reynolds D, Walsh MN, Fonarow GC | ||||
| Heart Rhythm 2009; 6:1727-1734 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Surgery | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry | ||||
| Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED. | ||||
| JACC 2009; 53(5):416-422 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Surgery | 2009 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Estimating healthcare burden of illness of hypertension among women using menopausal hormone therapy. | ||||
| Pelletier EM1, Chang J2, Mittapally R1, Nahum GG2, Gricar JA3 | ||||
| 1IMS Health, Watertown, MA, USA, 2Bayer HealthCare Pharmaceuticals, Wayne, NJ, USA, 3Independent Health Care Consultant, New York, NY, USA | ||||
| ISPOR 13th Annual International Meeting, 2008, May, Toronto, Ontario, Canada | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Burden of illness | |
| Cost-effectiveness of left ventricular-assist devices in end-stage heart failure. | ||||
| Hutchinson J1, Scott DA2, Clegg AJ3, Loveman E3, Royle P4, Bryant J3, Colquitt JL3. | ||||
| 1 IMS Health inc. Fourth Hurdle Consulting, London, UK 2 Oxford Outcomes, Oxford, UK 3 Southampton Health Technology Assessment Centre, Southampton, UK 4 University of Aberdeen, UK | ||||
| Expert Rev Cardiovasc Ther. 2008 Feb; 6(2):175-85 | ||||
| Manuscript in preparation | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Cost effectiveness | |
| The cost-utility of aliskiren in the treatment of mild to moderate hypertension. A Canadian health care system perspective | ||||
| Lee A, Barry SJ, Leiter L, Nanji A, Annemans L, Tucker D, Michaliszyn AF, Barbeau M, Vincze G | ||||
| ISPOR 13th Annual International Meeting, 2008, May 3-7, Toronto, Canada | ||||
| Poster | ||||
| Canada | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)70642-2/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Cost utility | |
| Gadofosveset in the management of peripheral arterial occlusive disease in Canada - a model approach focusing on diagnostic confidence | ||||
| Hass B1, Rebeira M2, Lungershausen J1, Jaszewski B2, D`Onofrio F2, Kienbaum S3 | ||||
| 1 IMS Health, Nuremberg, Germany 2 Bayer HealthCare, Toronto, ON, Canada 3 Bayer Schering Pharma AG, Berlin, Germany | ||||
| ISPOR 13th Annual International Congress, May 3-7, 2008, Toronto, Canada ISPOR 13th Annual International Congress, May 3-7, 2008,Toronto, Canada Value in Health, 2008, 11(3): A196 |
||||
| Abstract, Oral presentation, Poster | ||||
| Canada | ||||
| Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)70623-9/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Vascular disease | 2008 | English | Cost benefit, Cost effectiveness | |
| Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia. | ||||
| Bays H, Chapman R1, Fox K, Grandy S, SHIELD Study Group | ||||
| 1 IMS Health, Falls Church, VA, USA | ||||
| Current Medical Research and Opinion 2008;24(4):1179-86 | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Survey research | |
| Adherence to single−pill amlodipine/atorvastatin compared to other branded and generic CCB + statin combinations among US managed care enrollees | ||||
| Chapman R1, Hussein M,1 Benner J1,1 Roberts C | ||||
| 1 IMS Health, Falls Church, VA, US | ||||
| American Society of Hypertension 23rd Annual Scientific Meeting & Exposition, New Orleans, LA, May 14-17, 2008 | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective cohort analysis | |
| The cost and effectiveness of adherence-improving interventions for lipid-lowering and antihypertensive drugs. | ||||
| Chapman R1, Ferrufino C1, Kowal-Podmore S1, Classi P2, Roberts C2 | ||||
| 1 1 IMS Health, Falls Church, VA, US 2 Pfizer, New York, NY, US | ||||
| ISPOR 13th Annual International Meeting, Toronto, ON, Canada, May 3-7, 2008 | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Cost effectiveness | |
| Can adherence to antihypertensive therapy be used to promote adherence to statin therapy? | ||||
| Chapman R1, Pelletier EM2, Benner J1, Moller R3, Roberts C3 | ||||
| 1IMS Health, Falls Church, VA, USA, 2IMS Health, Watertown, MA, USA, 3Pfizer Inc., New York, NY, USA | ||||
| American Heart Association (AHA) 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, 2008, April 30-May 2, Baltimore, MD, USA | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective cohort analysis | |
| Hospital-based costs associated with VTE treatment regimens | ||||
| Merli G1, Ferrufino C2, Lin J3, Hussein M2, Battleman D2 | ||||
| 1 Thomas Jefferson Hospital, Philadelphia, PA, US 2 IMS Health, Falls Church, VA, US 3 Sanofi Aventis, Bridgewater, NJ, US | ||||
| J Thromb Haemost, 2008,6(7):1077-86. Epub 2008 Jul 1. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Economic evaluation | |
| In patients use of low-molecular-weight heparin maintains quality but reduces hospital-based treatment cost associated with venous thromboembolism prophylaxis. | ||||
| Ferrufino C1, Merli G2, Lin J3, Hussein M1 | ||||
| 1 IMS Health, Falls Church, VA, US 2 Thomas Jefferson Hospital, Philadelphia, PA, US 3 Sanofi Aventis, Bridgewater, NJ, US | ||||
| J Gen Int Med 2007;22(Suppl 1):60 | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Economic evaluation | |
| Inpatient enoxaparin reduces hospital-based costs associated with VTE prophylaxis. | ||||
| Merli G1, Ferrufino C2, Lin J3, Hussein M2, Battleman D2 | ||||
| 1 Thomas Jefferson Hospital, Philadelphia, PA, US 2 IMS Health, Falls Church, VA, US 3 Sanofi Aventis, Bridgewater, NJ, US | ||||
| AHA-QCOR annual meeting, Washington, DC, May 9-11, 2008 | ||||
| Abstract | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Economic evaluation | |
| Influencia del sexo en la mortalidad y el manejo del síndrome coronario agudo en España [Influence of Sex on Acute Coronary Syndrome, Mortality and Treatment in Spain]. | ||||
| Joaquín Alonso1, Héctor Bueno2, Alfredo Bardají3, Xavier García-Moll4, Xavier Badia5, Miquel Layola5, Ágata Carreño5 | ||||
| 1Hospital de Fuenlabrada. Fuenlabrada. Madrid. España. 2Hospital General Universitario Gregorio Marañón. Madrid. España. 3Hospital Juan XXIII. Tarragona. España. 4Hospital de la Santa Creu y Sant Pau. Barcelona. España. 5IMS Health Economics and Outcomes Research | ||||
| Rev Esp Cardiol Supl., 2008;8:8D-22D | ||||
| Article, Manuscript in preparation | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | Spanish | Epidemiological study | |
| Using Triple Antiplatelet Therapy in Patients with Non-ST Elevation Acute Coronary Syndrome Managed Invasively: A Cost-Effectiveness Analysis | ||||
| Latour-Pérez J1, de Miguel Balsa E1, Betegón L2, Badia X2 | ||||
| 1Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain; 2IMS Health Economics & Outcomes Research, Barcelona, Spain | ||||
| Value in Health 2008;11(5)853–861 | ||||
| Article | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Cost effectiveness | |
| A new measure for assessing Health-Related Quality of Life (HRQOL) in patients with atrial fibrillation: AF-QOL | ||||
| Arribas F Ormaetxe JM1, Peinado R2, Fernandez C, Ramírez P4, Badia X Lara N5 | ||||
| 1. Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, Spain 2. Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain 4. MEDA Pharma; Madrid, Spain 5. Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
| ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece | ||||
| Oral presentation | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Quality of life | |
| Risk and cost of the first hypertension-associated event, compliance and persistence in naive hypertension patients after initiating monotherapy | ||||
| Mathes J1, Kostev K2, Gabriel A1, Pirk O1, Schmieder RE3 | ||||
| 1 IMS Health, Nuremberg, Germany 2 IMS Health, Frankfurt, Germany, 3 Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany | ||||
| ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece | ||||
| Abstract, Oral presentation | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Discovery Benelux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia. | ||||
| Herregods MC, Daubresse JC, Michel G, Lamotte M, Vissers E, Vandenhoven G | ||||
| Acta Cardiologica, 2008, 63(4): 493-499 | ||||
| Article | ||||
| Belgium, Luxembourg, Luxemburg, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Economic evaluation | |
| Long-term cost-benefit ratio of cardiac rehabilitation after percutaneous coronary intervention. | ||||
| Dendale P, Hansen D, Berger J, Lamotte M | ||||
| Acta Cardiologica, 2008, 63: 451-456 | ||||
| Article | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Cost benefit | |
| Remote monitoring systems for patients with implanted cardiac devices | ||||
| Medical Services Advisory Committee (MSAC), Australian Government Department of Health and Ageing. | ||||
| Department of Health and Ageing, Canberra: Australia | ||||
| Report | ||||
| Australia | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Review | |
| Cost-Effectiveness of Stroke Unit Care Followed by Early Supported Discharge. | ||||
| Saka O1, Serra V2, Samyshkin Y3, McGuire A2, Wolfe CC1 | ||||
| 1 Division of Health and Social Care Research, King’s College, London, UK; 2 London School of Economics and Political Science, LSE Health and Social Care, London, UK; 3 IMS Health, London, UK. | ||||
| Stroke. 2009 Jan;40(1):24-9. Epub 2008 Nov 13 | ||||
| Article | ||||
| UK | ||||
| Abstract: http://stroke.ahajournals.org/cgi/content/abstract/40/1/24 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Cost effectiveness | |
| Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: A retrospective, cohort study. | ||||
| Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SSK. | ||||
| 1 IMS Health, Falls Church, VA, USA 2 IMS Health, Falls Church, VA, USA 3 Formerly of IMS Health, Falls Church, VA, USA | ||||
| Drugs & Aging 2008;25(10):885-892. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Adherence to single−pill amlodipine/ atorvastatin compared to other branded and generic CCB + statin combinations among U.S. managed care enrollees. | ||||
| Chapman R, Hussein M, Benner J, Roberts C. | ||||
| 1 IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US 3 Formerly of IMS Health, Falls Church, VA, US 4 Pfizer, Inc, New York, NY, US | ||||
| Journal of Clinical Hypertension 2008;10(5 Suppl A):A113. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective cohort analysis | |
| Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population | ||||
| García Rodríguez LA, Tacconelli S & Patrignani P | ||||
| Centro Español de Investigación Farmacoepidemiológica, Madrid | ||||
| J Am Coll Cardiol. 2008 Nov 11;52(20):1628-36. doi: 10.1016/j.jacc.2008.08.041. | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18992652 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Age threshold for routine aspirin treatment to prevent cardiovascular disease in patients without diabetes | ||||
| Bulugahapitiya U, Siyambalapitiya S, Sithole J, Fernando DJ & Idris I | ||||
| University of Sheffield | ||||
| Heart doi:10.1136/hrt.2008.150698 | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://heart.bmj.com/content/early/2008/08/15/hrt.2008.150698 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. | ||||
| Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J & Brindle P | ||||
| Division of Primary Care, 13th Floor, Tower Building, University Park, Nottingham | ||||
| Heart. 2008 Jan;94(1):34-9. Epub 2007 Oct 4. | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17916661 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Association between serious ischemic cardiac outcomes and medications used to treat diabetes. | ||||
| Margolis D J, Hoffstad O & Strom BL | ||||
| Department of Dermatology, University of Pennsylvania School of Medicine | ||||
| Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):753-9. doi: 10.1002/pds.1630. | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18613215 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2008 | English | Retrospective database analysis | |
| Declining public health burden of digoxin toxicity from 1991 to 2004. | ||||
| Haynes K, Heitjan D, Kanetsky P & Hennessy S | ||||
| Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine | ||||
| Clin Pharmacol Ther. 2008 Jul;84(1):90-4. Epub 2007 Dec 19. | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18091761 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2008 | English | Retrospective database analysis | |
| Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006. | ||||
| Molokhia M, McKeigue P, Curcin V & Majeed A | ||||
| Department of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine | ||||
| PLoS One. 2008 Jun 25;3(6):e2522. doi: 10.1371/journal.pone.0002522 | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18575628 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Variation in recorded blood pressure terminal digit bias in general practice. | ||||
| Harrison WN, Lancashire RJ & Marshall TP | ||||
| Department of Public Health and Epidemiology, University of Birmingham | ||||
| J Hum Hypertens. 2008 Mar;22(3):163-7. Epub 2007 Nov 29. | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18046433 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Clinical practice | 2008 | English | Retrospective database analysis | |
| Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom | ||||
| MacDonald TM & Morant SV | ||||
| Division of Medicine and Therapeutics, University of Dundee Ninewells Hospital and Medical School | ||||
| Br J Clin Pharmacol. 2008 May; 65(5): 775–786. Published online 2008 Feb 14. doi: 10.1111/j.1365-2125.2007.03072.x | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2432490/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Does an increase in serum creatinine after starting ACE inhibitors influence their discontinuation? | ||||
| Carnahan D, Haynes K, Sammel M, Holmes J & Turner B | ||||
| Healthcore Inc | ||||
| Pharmacoepidemiology and Drug Safety 17(S277) | ||||
| Abstract | ||||
| UK | ||||
| Abstract: https://vivo.upenn.edu/vivo/display/citfd206829 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Infectious disease | 2008 | English | Retrospective database analysis | |
| Risk of chronic end stage renal disease after use of ACE inhibitors compared to other antihypertensives or no-antihypertensive use in a cohort of diabetic patients in the United Kingdom | ||||
| Laudati J, Motsko S & Jones J | ||||
| Pharmacoepidemiology and Drug Safety 17(S233) | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.deggegroup.com/2008-ISPE%20-%20Diabetes-THIN.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Diabetes | 2008 | English | Retrospective database analysis | |
| Risk factors for thiazolidinedione related peripheral edema | ||||
| Tennis P, Roskell N, Andrews E & Rothman K | ||||
| RTI Health Solutions, Spain | ||||
| Pharmacoepidemiology and Drug Safety 17(S118-S119) | ||||
| Abstract | ||||
| Spain, UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Clinical outcomes associated with anticoagulant therapies in patient with incident heart failure: A retrospective analysis of a population based database | ||||
| Yuan Z, Weinstein R, Zhang J, Cheng M, Griffin G, Zolynas R, Lee M & Oppenheimer L | ||||
| Pharmacoepidemiology and Drug Safety 17(S1-S294) | ||||
| Abstract | ||||
| UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Measurement of baseline total cholesterol: new data from The Health Improvement Network (THIN) database | ||||
| Thompson R, O’Regan C, Morant S, Phillips B & Ong S | ||||
| Pfizer Limited, Walton Oaks, Dorking Road, Walton on the Hill, Tadworth, Surrey | ||||
| Primary Care Cardiovascular Journal 1(2):107-111 | ||||
| Article | ||||
| UK | ||||
| Abstract: www.pccj.eu/pdf/3108/Vol1_Num2_July_2008_p107-11114b2.pdf | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | Retrospective database analysis | |
| Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF | ||||
| Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN | ||||
| Circ Heart Failure 2008; 1:98-106 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2008 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Budget impact and medical resources used to control bleeds in patients hospitalized due to acute coronary syndrome (ACS) | ||||
| Guijarro P, Marimón F, Guindo J, Coves FJ, Sionis A, Pedrós M, Layola M | ||||
| Poster | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Budget impact | |
| Impacto socioeconómico de la hipercolesterolemia [Socioeconomic impact of hypercholesterolemia] | ||||
| Badia X1 | ||||
| 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
| Cholesterol, implications of an insufficient approach: from European Union to Autonomous govenrment reality. 2007 March 22, Valencia, Spain | ||||
| Conference | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | Spanish | Burden of illness | |
| Economic burden of disease of pulmonary arterial hypertension in Germany: an interim analysis of resource utilisation | ||||
| Ehlken B, Plesnila Frank C, Ghofrani A, Grimminger F, Hoeper M, Stähler G, Wilkens H, Berger K, Resch A. | ||||
| ISPOR 2007 10th Annual European Congress | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Burden of illness | |
| Translating Research into Action: Use of Premier Perspective™ transactional data to reduce hospital-based costs for the treatment and prevention of venous thromboembolism. | ||||
| David S. Battleman1 | ||||
| 1 IMS Health, Falls Church, VA, US | ||||
| 2007 Premier Breakthrough Leadership Conference, June 21-22nd, Orlando, Florida | ||||
| Keynote address | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Burden of illness | |
| Clinical and Economic Outcomes of Amlodipine/Atorvastatin Single-Pill Formulation in a Hypertensive Population | ||||
| Smith TW, Cherry SB, Tang SSK, Benner JS | ||||
| American Heart Association's 8th Annual Scientific Forum ON Quality OF Care AND Outcomes Research IN Cardiovascular Disease AND Stroke, Washington, DC, May 9-11th, 2007 | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Cost effectiveness | |
| Clinical and economic burden of nonadherence to lipid-lowering and antihypertensive therapy in a hypertensive population | ||||
| Cherry SB, Benner JS, Hussein MA, Tang SK, Nichol MB | ||||
| ISPOR 12th Annual International Meeting, May 19-23, 2007, Arlington, Virginia, USA | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Cost effectiveness | |
| Clinical and economic consequences of a single-pill combination of amlodipine/atorvastatin compared with a two-pill regimen in hypertensive patients with additional cardiovascular risk factors | ||||
| Smith TW, Cherry SB, Tang SSK, Benner JS | ||||
| Presented at the European Society of Cardiology Congress 2007, Vienna, Austria, September 1-5th, 2007 | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Cost effectiveness | |
| Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL) | ||||
| Badia X, Arribas F, Ormaetxe JM, Peinado R, Sainz de los Terreros M. | ||||
| IMS Health, Barcelona, Spain. xbadia@es.imshealth.com | ||||
| Health Qual Life Outcomes 2007;5:37 | ||||
| Manuscript in preparation | ||||
| Spain | ||||
| Abstract: http://www.hqlo.com/content/5/1/37/abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Quality of life | |
| Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrollees? | ||||
| Hussein MA, Chapman RH, Benner JS, Tang SSK, Solomon HA, Joyce A, Foody J | ||||
| American Society of Hypertension 22nd Annual Scientific Meeting and Exposition, Chicago, IL, May 19-22, 2007 | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Retrospective cohort analysis | |
| Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in United States managed care enrollees? | ||||
| Hussein MA, Chapman RH, Benner JS, Tang SSK, Solomon HA, Joyce A, Foody J | ||||
| Journal of the American College of Cardiology 2007; 49(9SupplA):288A; American College of Cardiology 56th Annual Scientific Session, New Orleans, LA, March 24-27, 2007; | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Retrospective cohort analysis | |
| Venous Thromboembolism (VTE) Treatment With Low Molecular Weight Heparin Reduces Total Hospital Costs And Vte-Related Readmission. | ||||
| Merli G, Ferrufino C, Lin J, Hussein M, Battleman D | ||||
| American Heart Association Quality of Care and Outcomes Research Conference, 2007, May 9-11, Washington, USA | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Economic evaluation | |
| Belgian budget impact analyses of aliskiren (tekturna/rasilez) in hypertension. | ||||
| Lecomte P1, Lamotte M2, Esposito G2, Annemans L3, Kotchie RW4, Munk VC5, Vincze G5 | ||||
| 1 Novartis Pharma, Vilvoorde, Belgium 2 IMSHealth, HEOR, Brussels, Belgium 3 Ghent University, Ghent, Belgium 4 IMSHealth, HEOR, London, UK; 5 Novartis Pharma AG, Basel, Switzerland | ||||
| ISPOR 13th Annual International Meeting, Toronto, Ontario, Canada - 3-7 May 2008 | ||||
| Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Budget impact | |
| Inpatient use of enoxaparin reduces hospital-based treatment costs associated with VTE treatment. | ||||
| Merli G, Ferrufino C, Lin J, Hussein M, Battleman D | ||||
| Annual meeting ASH, Atlanta, GA, December 2007 | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Economic evaluation | |
| Impacto económico y recursos empleados en el manejo del sangrado en pacientes ingresados por Síndrome Coronario Agudo [Economic impact and resources used in the management of blooding of patients treated for Acute Coronary Syndrome] | ||||
| Marimón F, Guindo J, Coves FJ, Sionis A, Pedrós M, Layola M, Guijarro P | ||||
| Congreso de la Sociedad Española de Cardiología 2007 october 18-20, Madrid, Spain | ||||
| Oral presentation | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | Spanish | Economic evaluation | |
| Cost-efectivitat del tractament del malalt amb hipertensió arterial [Cost-effectiveness of treatment of patient with arterial hypertension] | ||||
| Badia X1 | ||||
| 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain, | ||||
| 20 Jornades Catalanes sobre Hipertensió Arterial; 14 Reunió de la Societat Catalana d’Hipertensió Arterial 2007 December 18-19 Barcelona, Spain | ||||
| Oral presentation | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | Spanish | Cost effectiveness | |
| Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases. | ||||
| Annemans L, Lamotte M, Clarys P, Van den Abeele E | ||||
| Eur J Cardiovasc Prev Rehabil., 2007, 14(6): 815-824 | ||||
| Article | ||||
| Belgium | ||||
| Abstract: http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?View=Full&ID=22007002690 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Economic evaluation | |
| Coste-efectividad de la aspirina en la prevención cardiovascular. | ||||
| Lamotte M, Annemans L | ||||
| Med Clin Monogr (Barc), 2007, 7(7): 27-36 | ||||
| Article | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | Spanish | Cost effectiveness | |
| A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan. | ||||
| Tsutani K, Igarashi A, Fujikawa K, Evers T, Kubin M, Lamotte M, Annemans L | ||||
| Intern Med., 2007, 46(4): 157-162 | ||||
| Article | ||||
| Japan | ||||
| Abstract: http://www.unboundmedicine.com/medline/ebm/record/17301509/full_citation/A_health_economic_evaluation_of_aspirin_in_the_primary_prevention_of_cardiovascular_disease_in_Japan_ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Economic evaluation | |
| Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany. | ||||
| Berger K 1, Hessel F 2,3, Kreuzer J 4, Smala A 5, Diener HC 6. | ||||
| 1 University Hospital Munich, Dept. of Hemostaseology and Transfusion Medicine, Economic Working Group, Munich, Germany 2 HEOR Sanofi-Aventis, Berlin, Germany 3 Institute for Health Care Management, University of Duisburg-Essen, Campus Essen, Essen, Germany 4 St. Vincent- Hospital Limburg, Dept. of Cardiology, Limburg, Germany 5 IMS Health, Munich, Germany 6 University Hospital Essen, Neurological Clinic and Policlinic, Essen, Germany | ||||
| Curr Med Res Opin. 2008 Jan; 24(1): 267-74. | ||||
| Article | ||||
| Germany | ||||
| Abstract: http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=22008000363 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Cost effectiveness | |
| The contraceptive patch in relation to ischemic stroke and acute myocardial infarction. | ||||
| Jick S, Jick H | ||||
| Pharmacotherapy., 2007, 27(2): 218-20 | ||||
| Article | ||||
| USA | ||||
| Abstract: http://www.druglib.com/abstract/ji/jick-ss_pharmacotherapy_20070200.html | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Retrospective database analysis | |
| Reduced Mortality Rate after Intensive Statin Therapy in Managed-Care Patients. | ||||
| Kuntze M, Ollendorf D | ||||
| Value In Health, 2007, 10(2): 161-169 | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Retrospective database analysis | |
| Comparative study of modified release alpha-blocker exposure in elderly patients with fractures | ||||
| Hall GC, McMahon AD. | ||||
| Grimsdyke House, London | ||||
| Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):901-7. | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17443863 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Orthopedics | 2007 | English | Retrospective database analysis | |
| Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996 2005. | ||||
| Davies AR, Smeeth L & Grundy EM | ||||
| Department of Epidemiology and Population Health, Centre for Population Studies, London School of Hygiene and Tropical Medicine | ||||
| Eur Heart J. 2007 Sep;28(17):2142-7. Epub 2007 Jul 18. | ||||
| Abstract, Article | ||||
| UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17636307 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Retrospective database analysis | |
| The prescribing of statins and mortality following a diagnosis of heart failure | ||||
| Ryan R, McManus RJ, Mant J, Macleod J & Hobbs R | ||||
| University of Birmingham | ||||
| Annual Research Conference - West Midlands Deanery, Department of Primary Care & General Practice | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.docstoc.com/docs/149802435/THINBibliography | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Retrospective database analysis | |
| Differences in cholesterol levels between statin and fibrate treated patients in French, Italian and UK primary care | ||||
| Blak BT, Maguire A & Schwalm MS | ||||
| Cegedim | ||||
| ISPOR - 10th Annual European Congress Dublin, Ireland
Value in Health 10(6):A407 |
||||
| Abstract, Poster | ||||
| France, Italy, UK | ||||
| Abstract: http://www.ispor.org/congresses/ireland0507/posters3.aspx | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2007 | English | Retrospective database analysis | |
| Patterns of cholesterol levels in patients treated with lipid lowering drugs in UK primary care | ||||
| Maguire A, Douglas I & Smeeth L | ||||
| Cegedim | ||||
| Pharmacoepidemiology and Drug Safety 16:S1-S274 (481) | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://researchonline.lshtm.ac.uk/8494/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2007 | English | Retrospective database analysis | |
| A propensity score controlled cohort study to investigate the effects of Statins | ||||
| Douglas IJ, Smeeth & Evans SJ | ||||
| London School of Hygiene and Tropical Medicine | ||||
| Pharmacoepidemiology and Drug Safety 16:S1-S274 (474) | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://researchonline.lshtm.ac.uk/8492/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | Retrospective database analysis | |
| A propensity score controlled cohort study to investigate the effects of statins | ||||
| Douglas IJ, Smeeth & Evans SJ | ||||
| London School of Hygiene and Tropical Medicine | ||||
| Pharmacoepidemiology and Drug Safety 16:S1-S274 (474) | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://researchonline.lshtm.ac.uk/8492/ | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Vascular disease | 2007 | English | Retrospective database analysis | |
| Comprehensive coronary artery disease care in a safety-net hospital: results of Get With The Guidelines quality improvement initiative | ||||
| Krantz MJ, Baker WA, Estacio RO, Haynes DK, Mehler PS, Fonarow GC, Long CS | ||||
| J Manag Care Pharm 2007; 13:319-24 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Improving outcomes for acute coronary syndrome patients in the hospital setting: successful implementation of the American Heart Association ‘‘Get With The Guidelines’’ program by phase I cardiac rehabilitation nurses | ||||
| Flynn FM, Cafarelli M, Petrakos K, Christophersen P | ||||
| J of Cardiovasc Nursing 2007; 22(3):166-176 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Improved treatment of hospitalized coronary artery disease patients with the Get With The Guidelines program | ||||
| LaBresh KA, Fonarow GC, Smith SC, Bonow RO, Smaha LC, Tyler PA, Hong Y, Albright D, Ellrodt AG | ||||
| Critical Pathways in Cardiology 2007; 6(3):98-105 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and non-intervention patients in the Get With the Guidelines database | ||||
| Hiratzka L, Eagle KA, Liang L, Fonarow GC, LaBresh KA, Peterson ED | ||||
| Circ Surg Supp 2007; 116(11 Suppl):I207-12 | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Multidisciplinary Rounds (MDR): an implementation system for sustained improvement in the American Heart Association's Get With The Guidelines program | ||||
| Ellrodt AG, Glasener R, Kradel K, Bercury C, Ferrarin A, Jewell D, Frechette C, Seckler P, Reed J | ||||
| Crit Path Cardiol 2007; 6(3):106-116 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Hospital-based outcomes associated with non-traumatic subarachnoid hemorrhage | ||||
| Van Den Bos JV, Dreyer NA | ||||
| ISPOR. Arlington, VA, May, 2007 | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Medical therapies and invasive treatments for coronary artery disease in overweight patients: understanding the “obesity paradox” in the Get With The Guidelines database | ||||
| Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC | ||||
| Am J Cardiology 2007; 100:1331-1335 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry | ||||
| Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB | ||||
| JACC 2007; 50(8):767-777 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| A gender and racial gap in internal cardioverter defibrillator use among hospitalized heart failure patients | ||||
| Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM | ||||
| JAMA 2007; 298(13):1525-1532 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) | ||||
| Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, Gheorghiade M, O’Connor CM, Sun JL, Yancy CW, Young JB, Fonarow GC | ||||
| Am Heart J 2007; 154(2):277.e1-7 | ||||
| Abstract | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF) | ||||
| Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Pieper K, Sun JL, Yancy CW, Young JB | ||||
| Arch Intern Med 2007; 167(14):1493-1502 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Performance measures and outcomes for patients hospitalized with heart failure | ||||
| Fonarow GC, et al | ||||
| JAMA 2007; 297(14):1547-1549 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry | ||||
| Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood T, Mehra M, O’Connor CM, Reynolds D, Walsh MN | ||||
| Am Heart J 2007; 0(0):1-27 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF | ||||
| Albert NM, Fonarow GC, Abraham WT, Chiswell K, Stough WG, Gheorghiade M, Greenberg GH, O’Connor CM,SUN JL, Yancy CW, Young JB | ||||
| J Cardiac Failure 2007; 13(3):189-198. | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| A gender and racial gap in internal cardioverter defibrillator use among hospitalized Heart failure patients | ||||
| Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM | ||||
| JAMA 2007; 298(13):1525-32 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Surgery | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and non-intervention patients in the Get With The Guidelines database | ||||
| Hiratzka L, Eagle KA, Liang L, Fonarow GC, LaBresh KA, Peterson ED | ||||
| Circ Surg Supp 2007; 116(11 Suppl):I207-212 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Surgery | 2007 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Inpatient Use Of Low Molecular Weight Heparin (Lmwh) Reduces Hospital-Based Treatment Costs Associated With Venous Thromboembolism (Vte) Prophylaxis | ||||
| Ferrufino CP1, Lin J2, Hussein MA1, Battleman DS1 | ||||
| 1 IMS Health, Falls Church, VA, USA 2 Sanofi Aventis, NJ, USA | ||||
| Society of General Internal Medicine 30th Annual Meeting, April 25-28, 2007, Toronto, Canada | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Cost effectiveness | |
| Short-term clinical consequences of nonadherence in patients hypertension and multiple risk factors. | ||||
| Cherry SB, Hussein MA, Nichol MB, Tang SS, Benner JS. | ||||
| Circulation 2006; 114(18 Suppl II):II-906. | ||||
| Abstract | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Impact of pill burden on adherence to antihypertensive and lipid-lowering therapy. | ||||
| Benner JS, Petrilla AA, Schwartz JS, Rosenberg N, Chapman RH, Tang S. | ||||
| Journal of Clinical Hypertension 2006; 8(5SupplA):A214. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Patterns and predictors of adherence to concomitant antihypertensive and lipid-lowering medications in elderly patients. | ||||
| Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang S. | ||||
| Circulation 2006; 113(21):13. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Retrospective database analysis | |
| Patterns and predictors of concomitant statin use in patients initiating antihypertensive therapy. | ||||
| Chapman RH, Petrilla AA, Berman L, Benner JS, Tang S. | ||||
| Journal of Clinical Hypertension 2006; 8(5SupplA):A214-A215. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Use of an indirect effect model to describe the LDL cholesterol lowering effect by statins in hypercholesterolemic patients. | ||||
| Faltaos Dw, Urien S, Carreau V, Chauvenet M et al. | ||||
| Fundam Clin Pharmacol. 2006 Jun;20(3):321-30. | ||||
| Manuscript in preparation | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Risk of nonfatal thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 ug of ethinyl estradiol. | ||||
| Jick SS, Kaye JA, Russmann S, Jick H | ||||
| Contraception, 2006, 73: 223-228 Contraception; 73:223-228 |
||||
| Article, Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Womens Health | 2006 | English | Retrospective database analysis | |
| Therapeutic goal attainment in patients with hypertension and dyslipidemia. | ||||
| Johnson ML, Pietz K, Battleman DS, Beyth RJ. | ||||
| Medical Care. 2006 Jan;44(1):39-46. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease. | ||||
| Lamotte M, Annemans L, Evers T, Kubin M | ||||
| Pharmacoeconomics, 2006, 24(2): 155-169 Pharmacoeconomics; 24:155-69 |
||||
| Article, Manuscript in preparation | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Health economics | 2006 | English | Economic evaluation | |
| Patterns and predictors of adherence to concomitant antihypertensive and lipid-lowering medication in elderly patients. | ||||
| Petrilla AA, Chapman RH, Rosenberg N, Benner JS, Schwartz JS, Tang S. | ||||
| Journal of Clinical Hypertension 2006; 8(5SupplA):A143-A144. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Candesartan bei Herzinsuffizienzpatienten - eine kosteneffektive Therapieoption? [Candesartan as a treatment for patients with heart insufficiency - a cost-effectiveness therapy option?] | ||||
| Sonntag F1, Schoeffski O2, Voelkl M3 | ||||
| 1 Bundesverband niedergelassener Kardiologen Deutschland, Henstedt-Ulzburg, Germany 2 Lehrstuhl fuer Gesundheitsmanagement, Wirtschafts- und Sozialwissenschaftliche Fakultaet, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Germany 3 IMS Health, Nuremberg, Germany | ||||
| Münchener Medizinische Wochenschrift (MMW), Fortschritte der Medizin Originalien, I/2006 (148. Jg.): 41-49, 2006. | ||||
| Manuscript in preparation | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | German | Cost effectiveness | |
| Assessing health state utilities in elderly patients at cardiovascular risk. | ||||
| Winkelmayer WC, Benner JS, Glynn RJ, Schneeweiss S, Wang PS, Brookhart MA, Levin R, Jackson JD, Avorn J | ||||
| Med Decis Making 2006;26:247-254. | ||||
| Manuscript in preparation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and Prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA Populations. Implications for COX-2 cardiovascular profile. | ||||
| Arellano FM, Ulcickas Yood M, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. | ||||
| Pharmacoepidemiology and Drug Safety 2006;15:861-872. Pharmacoepidemiology and Drug Safety, 2006,15(12): 861-72 |
||||
| Article, Manuscript in preparation | ||||
| UK, USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Methodology | 2006 | English | Retrospective database analysis | |
| A health economic evalutation of aspirin in the primary prevention of cardiovascular disease. | ||||
| Lamotte M, Annemans L, Evers T, Kubin M, Hu S | ||||
| ISPOR 2nd Asia-Pacific conference, Shanghai, China | ||||
| Poster | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Medical resource utilization in non-hemorrhagic stroke in a commercially-insured US population. | ||||
| McCollam PL, Ollendorf DA, Dennett SL | ||||
| International Stroke Conference Kissimee, USA | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Risk Evaluation and Communication Health Outcomes Utilization Trial (REACH OUT) | ||||
| Benner JS, Cherry SB, Erhardt L, Moller RA, Rajicic N, Gaciong Z et al | ||||
| European Society of Cardiology Congress , Vienna, Austria, September 3, 2007 | ||||
| Poster | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Economic evaluation | |
| Prevalence of dyslipidemia estimated from a self-reported survey versus clinical and laboratory evaluation: Comparison of SHIELD and NHANES data. | ||||
| Bays HE, Chapman RH, Grandy S, and SHIELD Study Group. | ||||
| XIV International Symposium on Atherosclerosis, Rome, Italy, June 18-22, 2006. | ||||
| Oral presentation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Clinical burden of non-adherence in patients with hypertension and multiple risk factors. | ||||
| Hussein MA, Cherry SB, Nichol MB, Tang S, Benner JS. | ||||
| International Society of Hypertension (ISH 2006).October, 2006. Fukuoka, Japan. | ||||
| Oral presentation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Knowledge, attitudes, and behavior of individuals with multiple cardiovascular risk factors: Data from the Study to Help Improve early Evaluation and management of risk factors Leading to Diabetes (SHIELD). | ||||
| Lewis SJ, Chapman R, Grandy S, for the SHIELD Study Group. | ||||
| 4th World Congress on Insulin Resistance Syndrome, Las Vegas, NV, October 5-7, 2006. | ||||
| Oral presentation | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | ||
| Cost Minimization analysis of Bivalirudin versus Heparin plus planned abxicimab in patients undergoing Percutaneous Coronary intervention | ||||
| Cequier A, Morís C, Badia X, Lara N | ||||
| Rev Esp Econ Salud 2006;5(3):168-76 | ||||
| Article | ||||
| Spain | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | Spanish | Cost analysis | |
| Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation. | ||||
| Annemans L, Lamotte M, Kubin M, Evers T, Verheugt FW | ||||
| Int J Clin Pract., 2006, 60(9): 1129-1137 | ||||
| Article | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Economic evaluation | |
| A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. | ||||
| Lamotte M, Annemans L, Kawalec P, Zoellner Y | ||||
| Pharmacoeconomics, 2006, 24(8): 783-795 | ||||
| Article | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Economic evaluation | |
| [Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease] | ||||
| Lamotte M, Pinol C, Brotons C, Annemans L, Guardiola E, Evers T, Kubin M | ||||
| Rev Esp Cardiol., 2006, 59(8): 807-815 | ||||
| Article | ||||
| Belgium | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | Spanish | Economic evaluation | |
| Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany. | ||||
| Brüggenjürgen B, Lindgren P, Ehlken B, Rupprecht HJ, Willich SN. | ||||
| Eur J Health Econ. 2007; 8: 51-7. | ||||
| Article | ||||
| Germany | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Cost effectiveness | |
| Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch. | ||||
| Jick S, Jick H | ||||
| Contraception, 2006, 74(4): 290-2 | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Retrospective database analysis | |
| Antirheumatic drug use and the risk of acute myocardial infarction. | ||||
| Suissa S, Bernatsky S, Hudson M | ||||
| Arthritis Rheum., 2006; 55(4): 531-6 | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Retrospective database analysis | |
| Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. | ||||
| Jick S, Kaye J, Russmann S, Jick H | ||||
| Contraception., 2006, 73(3):223-8 | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Retrospective database analysis | |
| Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. | ||||
| MacDougall D, Feliu A, Boccuzzi S, Lin J | ||||
| Am J Health Syst Pharm., 2006; 63(20 Suppl 6): S5-15 | ||||
| Article | ||||
| USA | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | Retrospective database analysis | |
| Antihypertensive drug budget impact of the Angiotensin II Receptor Blockers (ARB) in the UK | ||||
| Blak BT, Weir MR, Simoni-Wastila L, Shaya FT, Cooke CE & Mullins CD | ||||
| Cegedim | ||||
| ISPOR - 10th Annual European Congress Dublin, Ireland
Value in Health 9(6):A343 |
||||
| Abstract, Poster | ||||
| UK | ||||
| Abstract: https://www.infona.pl/resource/bwmeta1.element.elsevier-c9cc9fe7-cb84-35ac-b478-71d6fba71b9d | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2006 | English | Retrospective database analysis | |
| Factors That Predict Switching Phosphodiesterase Type 5 Inhibitor Medication in the United Kingdom | ||||
| Kell P, Hvidsten K, Morant S, Harnett J & Bridge S | ||||
| Archway Sexual Health Clinic, London | ||||
| The Journal of Sexual Medicine 3(s3):199 | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.sexualmedicine.org.uk/links.html | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Urology | 2006 | English | Retrospective database analysis | |
| Trends in Angiotensin II Receptor Blocker (ARB) prescribing among general practitioners in the UK | ||||
| Blak B T, Mullins CD, Simoni-Wastila L, Shaya FT, Cooke CE & Weir MR | ||||
| Cegedim | ||||
| Value in Health 11/2006; 9(6). DOI: 10.1016/S1098-3015(10)63208-1 | ||||
| Abstract | ||||
| UK | ||||
| Abstract: http://www.researchgate.net/publication/251647986_Trends_in_angiotensin_II_receptor_blocker_%28ARB%29_prescribing_among_general_practitioners_in_the_UK | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous | 2006 | English | Retrospective database analysis | |
| Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations Implications for COX-2 cardiovascular profile | ||||
| Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A & Rothman KJ | ||||
| Risk Management Resources, LLC Bridgewater | ||||
| Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):861-72. | ||||
| Abstract | ||||
| UK, USA | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17086563 | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Miscellaneous, Pain | 2006 | English | Retrospective database analysis | |
| Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes | ||||
| Brogan GX Jr, Peterson ED, Mulgund J, Bhatt DL, Ohman EM, Gibler WB, Pollack CV Jr, Farkouh ME, Roe MT | ||||
| Diabetes Care 2006; 29(1):9-14 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis | ||||
| Nallamothu BK, Wang Y, Magid DJ, McNamara RL, Herrin J, Bradley EH, Bates ER, Pollack CV Jr, Krumholz HM; National Registry of Myocardial Infarction Investigators | ||||
| Circulation 2006; 113(2):222-229 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Overview of the American Heart Association “Get With The Guidelines” Programs. Coronary heart disease, stroke, and heart failure | ||||
| Hong Y, Labresh KA | ||||
| Crit Path Cardiol. 2006; 5:179-186 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002 | ||||
| McNamara RL, Herrin J, Bradley EH, Portnay EL, Curtis JP, Wang Y, Magid DJ, Blaney M, Krumholz HM; NRMI Investigators | ||||
| JACC 2006; 47(1):45-51 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Association between hospital process performance and outcomes among patients with acute coronary syndromes | ||||
| Peterson ED, Roe MT, Mulgund J, DeLong ER, Lytle BL, Brindis RG, Smith SC Jr, Pollack CV Jr, Newby LK, Harrington RA, Gibler WB, Ohman EM | ||||
| JAMA 2006; 295(16):1912-20 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge | ||||
| Tricoci P, Roe MT, Mulgund J, Newby LK, Smith SC Jr, Pollack CV Jr, Fintel DJ, Cannon CP, Bhatt DL, Gibler WB, Ohman EM, Peterson ED, Harrington RA | ||||
| Arch Intern Med 2006; 166(7):806-11 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure | ||||
| Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC | ||||
| JAMA 2006; 296(18):2217-2226 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems | ||||
| Bradley EH, Curry LA, Webster TR, Mattera JA, Roumanis SA, Radford MJ, McNamara RL, Barton BA, Berg DN, Krumholz HM | ||||
| Circulation 2006; 113(8):1079-85 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis | ||||
| Nallamothu BK, Wang Y, Magid DJ, McNamara RL, Herrin J, Bradley EH, Bates ER, Pollack CV Jr, Krumholz HM; National Registry of Myocardial Infarction Investigators. | ||||
| Circulation 2006; 113(2):222-229 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Surgery | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |
| Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover registry | ||||
| Williams DO, Abbott JD, Kip KE | ||||
| Circulation 2006; 114(20):2154-2162 | ||||
| Article | ||||
| Condition | Year | Language | Analysis type | |
| Cardiovascular disease, Surgery | 2006 | English | RWLPR (Real-World Late Phase Research-quintiles | |